<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<!--
-->
<!-- %html{'xmlns'=>'http://www.w3.org/1999/xhtml', 'xml:lang'=>'en', 'lang'=>'en'} -->
<html>
<head>
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"d64d3db899","applicationID":"125361","transactionName":"dAkNQBFbXFUEREkBCVQTDlENQB9dDlUTCANZEkxHC1tH","queueTime":0,"applicationTime":3474,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
<title>
Borrome v. Attorney General, 687 F.3d 150 (3d Cir. 2012), Court Opinion - Bloomberg Law 

</title>
<meta content='NOINDEX, NOFOLLOW' name='ROBOTS'>
<meta content='telephone=no' name='format-detection'>
<meta content='BLAW' name='apple-mobile-web-app-title'>
<meta name="csrf-param" content="authenticity_token"/>
<meta name="csrf-token" content="NiJ+70&#47;qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA="/>
<script src="/min_assets/framework.js?1389213936" type="text/javascript"></script>

<script src="/javascripts/daterange.js?1380743058" type="text/javascript"></script>
<script src="/javascripts/document/document.js?1382459272" type="text/javascript"></script>
<script src="/javascripts/document/document_viewer.js?1383685414" type="text/javascript"></script>
<script src="/javascripts/document/bciteutils.js?1388683076" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.query.js?1342203941" type="text/javascript"></script>
<script src="/javascripts/browser/browser.js?1387565892" type="text/javascript"></script>
<script src="/javascripts/document/image_viewer.js?1366129555" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.selection.js?1375450295" type="text/javascript"></script>
<script src="/javascripts/jquery/jquery.bb-copywithcitation.js?1383771008" type="text/javascript"></script>
<script src="/javascripts/document/copy_with_cite.js?1382560939" type="text/javascript"></script>
<script src="/javascripts/document/notepad.js?1366310522" type="text/javascript"></script>

<link href="/stylesheets/yui2/yui2_combo.css?1288273584" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_v2.css?1391022004" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/min_assets/framework.css?1391022047" media="screen,print" rel="stylesheet" type="text/css" />
<!--[if IE]>
<link href="/stylesheets/ie.css?1391022010" media="screen,print" rel="stylesheet" type="text/css" />
<![endif]-->
<link href="/stylesheets/search/search_results.css?1391022036" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document.css?1391022003" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/document_viewer.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/search/tree_view.css?1391022037" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/browser/browser_enhanced.css?1391021984" media="print,screen" rel="stylesheet" type="text/css" />
<style type='text/css'>
#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6 { font-family:Times New Roman, Times, serif; }
				#content_document pre {
				white-space: pre-wrap;
				white-space: -moz-pre-wrap;
				white-space: -pre-wrap;
				white-space: -o-pre-wrap;
				word-wrap: break-word;
				font-family: Bloomberg Fixed 2 Unicode;
			}
			
			#content_document .page_no { 
				font-weight:bold;
				text-decoration:none;
			}
			
			#content_document .highlight { 
				font-weight:bold; 
				background-color:yellow; 
				color:black;
			}
			
			#content_document .bcitehi { 
				font-weight:bold; 
				background-color:violet; 
				color:black;
			}
			
			/*.UNICODE {
			}
			
			#content_document blockquote {
			}
			
			#content_document em {
			}   
			
			#content_document .tableofcontents {
			}
			
			#content_document div.blockgroup {
			}
			
			#content_document p.opinion_text {
			}  */
			
			#content_document, #content_document h1, #content_document h2, #content_document h3, #content_document h4, #content_document h5, #content_document h6, #content_document p, #content_document li, #content_document td, #content_document th, #content_document div {
				font-size: 11pt;
			}
			
			#content_document .main {
				text-align:center; 
				font-weight:bold; 
				color:black;
			}
			
			#content_document .ftnote { 
				font-style:italic;
			}
			
			#content_document .headline {
				font-weight:bold; 
				color:black;
			} 
			
			#content_document p.group{
				padding-top: 0; 
				padding-bottom: 1px; 
				padding-left: 0; 
				padding-right: 0;
				margin-top: 0; 
				margin-bottom: 1px; 
				margin-left: 0; 
				margin-right: 0;
			}
			
			#content_document .big {
				font-size: 13pt;
			}
			
			#content_document .indent {
				text-indent:2.5em;
			}
			
			#content_document .level2 {
				margin-left:2.5em;
				margin-right:2.5em;
			} 
			
			#content_document .level3 {
				margin-left:5em;
				margin-right:5em;
			} 					
			
			#content_document .level4 {
				margin-left:7.5em;
				margin-right:7.5em;
			} 					
			
			#content_document .level5 {
				margin-left:10em;
				margin-right:10em;
			} 					
			
			#content_document .level6 {
				margin-left:12.5em;
			} 					
			
			#content_document a.sup {
				font-size: 6pt; 
				vertical-align: top;
			}
			
			#content_document a.sup1 {
				font-size: 8pt; 
				vertical-align: top;
			}
			
			#content_document em.italic {
				font-style: italic;
			}
			
			#content_document em.bold {
				font-weight: bold;
				font-style: normal;
			}
			
			#content_document em.bold-big {
				font-size: 13pt; 
				font-weight: bold;
			}
			
			#content_document em.underline {
				font-style:normal; 
				text-decoration: underline;
			}
			
			#content_document em.bold-ital {
				font-weight: bold; 
				font-style: italic;
			}
			
			#content_document em.bold-underline {
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.ital-underline {
				font-style: italic; 
				text-decoration: underline;
			}
			
			#content_document em.ital-bold-underline { 
				font-style: italic; 
				font-weight: bold; 
				text-decoration: underline;
			}
			
			#content_document em.small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document em.strike {
				font-style: normal;
				text-decoration: line-through;
			}
			
			#content_document .small-cap {
				font-style:normal; 
				font-variant: small-caps;
			}
			
			#content_document h1.organization {
				font-weight: bold; 
				text-align:center; 
				font-style: normal;
			} 
			
			#content_document h2.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:2.5em; 
				margin-right:2.5em;
			}
			
			#content_document h3.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:5em; 
				margin-right:5em;
			}
			
			#content_document h4.organization {
				font-weight: bold;
				text-align:left;
				margin-left:7.5em; 
				margin-right:5em;
			}
			
			#content_document h5.organization {
				font-weight: bold; 
				text-align:left;
				margin-left:10em; 
				margin-right:5em;
			}
			
			#content_document h2.citation {
				font-weight: bold; 
				text-align:left;
			}
			
			#content_document div.blcitation {
				font-size: 7pt; 
				text-align:center;
			}
			
			#content_document .italic {
				font-style:italic;
			}	
			
			#content_document ul.dash {
				list-style-type: none;
			}
			
			#content_document ul.bullet {
				list-style-type: disc;
			}
			
			#content_document ul.none {
				list-style-type: none;
			}
			
			#content_document li.off {
				list-style-type: none; 
			}
			
			#content_document .mypre { 
				font-size: 100%;
			}
			
			#content_document .TOC {
				text-align:left;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}
			
			#content_document .TOC hr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .bluehr { 
				color:#339999;  
				background-color:#339999;  
				width:100%;  
				clear: both;  
				border: none;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 500;
				text-align: center;
			}
			
			#content_document .tocentry {
				text-indent:-18px;
				padding-left:18px;
				color: #003399;
				font-weight: 700;
			}
			
			#content_document .doctext {  
				margin:0 auto;  
				text-align: left;  
			}				 
			
			#content_document span.PAGE { 
				color: black; 
				font-weight: bold 
			}
			
			#content_document a:link {  	
				color: #003399;  
				font-weight: 700;
			}
			
			#content_document a:visited {  
				color: #660066;   
				font-weight: 700;
			}
			
			#content_document .fn{  
				padding-left: 50 px; 
				font-weight: 550;
			}				
			
			#content_document .fr a:link {  
				color: #003399;  
				font-weight: 600;
			}
			
			#content_document .fr a:visited {  
				color: #660066;  
				font-weight: 600;
			}
			
			#content_document .headinga { 
				color: #339999;   
				font-size: 20px;
				font-weight: 600;
				text-align: center;
			}
			
			#content_document .volume {  
				text-align:center;  
				padding:5px;  
				margin:0 auto;  
				color: #000000;  
				font-weight: 500;
			}				
			
			#content_document h2.blcitation {
				font-size: 7pt; 
				text-align:center; 
				white-space:nowrap;
			}
			
			#content_document cite.blcitation {
				white-space:nowrap;
			}
			
			#content_document table.page_legend { 
					width: 100px; 
					text-align: left; 
					background-color: white; 
					font-family: Bloomberg Proportional Unicode;
					font-size: 12px
			}
			#content_document div.page_text {  padding-left: 50 px; margin:0 0 0 50px;  text-align: center;  width:100px; font-size: 12px}

			#content_document .smalllinks{  text-align: right;  font-size: 10px;  font-weight: 500;}		
			
			#content_document .opinion_headnotes{
				margin-top:6px;
				margin-bottom:6px;
			}
			
			#content_document .headnote_group{
				padding: 10px 10px 2px 10px;
				background-color: #ECECEC;
				margin-top:4px;
				margin-bottom:10px;
			}
			
			#content_document .headnote_group_header{
				font-weight: bold;
				margin-bottom: 8px;
			}
			
			#content_document .opinion_headnote{
				clear:both;
				padding-bottom: 4px;
				margin-bottom:10px;
			}
			
			#content_document .highlighted_headnote{
				background-color: #FFFF22;
			}
			
			#content_document .headnote_link{
				font-weight:bold;
				text-decoration: none;
			}
			
			#content_document .show_hide_headnotes{
			}
			
			#content_document .clearfix:after {
				clear:both;
				content: ".";
				height:0px;
				display:block;
				visibility:hidden;
			}
			
			/* BNA Headnotes */
			
			#content_document .headnotesContainer {
				margin: 12px 0;
				padding: 12px 0;
				border-top: 1px solid #000;
				border-bottom: 1px solid #000;
			}
			
			#content_document .headnotesContainer .headnotesContainerTitle {
				font-size: 16px;
				font-weight: bold;
				text-align: center;
			}
			
			#content_document .headnotesContainer .headnoteTitle {
				padding: 8px 12px;
				background-color: #dedede;
				margin: 24px 0 0 0;
				font-size: 16px;
				font-weight: bold;
				text-transform: uppercase;
			}
			
			#content_document .headnotesContainer .headnote {
				margin-left: 24px;
			}
			
			#content_document .headnotesContainer .headnote .headnoteSlug {
				margin-top: 12px;
				font-size: 16px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteDescriptor {
				margin-top: 12px;
				font-weight: bold;
			}
			
			#content_document .headnotesContainer .headnote .headnoteToggle .headnoteText {
				margin-bottom: 12px;
			}
		
</style>
<link href="/stylesheets/yui_calendar.css?1391022047" media="print,screen" rel="stylesheet" type="text/css" />
<link href="/stylesheets/docviewer_overrides.css?1391022005" media="print,screen" rel="stylesheet" type="text/css" />

<link href="/stylesheets/print.css?1391022029" media="print" rel="stylesheet" type="text/css" />
<link href='/images/favicon.ico' rel='shortcut icon'>
</head>
<body class='securities  document '>
<div class='container'>
<div id='page_loader'></div>
<div class='printHeader printOnly'>
<img src='/images/print_header.jpg'>
<div class='user'>
<span>
Prepared for: Susan Yeh
</span>
</div>
</div>
<div class='topBarHolder printHide'>
<div class='topBar'>
<ul class='topBarElements'>
<li class='skip'>
<a href="#primary_content" tabindex="1">Skip Navigation</a>
</li>
<li class='logout'>
<a href="/log_out.htm" id="logoutButton" onclick="generateExplicitLogoutEvent();">Logout</a>
</li>
<li id='help'>
<a href="/help" target="_blank">Help</a>

</li>
<li id='user'>
<a href="/settings">Susan Yeh</a>

</li>
<li class='withNotifications' id='client_matter'>
<div class='clientMatterDropDown'>
<div>Client Matter</div>
<div class='skinButton blueAlert' style='display:none'>
<span id='currentClientMatter'>

</span>
</div>
<span class='noneSelected' style=''>
&nbsp;(None Selected)
</span>
<div class='expandable'></div>
</div>
<div class='topNavDropdown' id='sub_client_matter'>
<ul>
<li style='display:none'>
<a class='remove_client_matter_menu_item' href='#' onclick='return true;' title='Remove Current Client Matter'>
Remove Current Client Matter
</a>
</li>
<li>
<a class='enter_client_matter_menu_item' href='#' onclick='return true;' title='Enter Client Matter'>
Enter Client Matter
</a>
</li>
</ul>
</div>

</li>
<li class='withNotifications' id='alerts'>
<a href="/alerts/inbox"><div id='unreadAlertsCount'>
Saved Searches & Alerts
</div>
</a>
</li>
<li class='withNotifications' id='downloads'>
<a href="/download/download_center"><div id='unreadDownloadsCount'>
<div>Downloads</div>
</div>
</a>
</li>
<li id='research_trail'>
<a href="/research_trail"><div>Research Trail</div>
</a>
</li>
<li id='workspaces'>
<a href="/workspaces"><div>Workspaces</div>

</a></li>
</ul>
</div>
</div>

<div class='topMenu textBkDark printHide' id='top_menu'>
<div class='contextHolder'>
<a href='/home'>
<h1 class='logo'></h1>
</a>
<div class='menuRow'>
<ul class='menuItems'>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_HOME' onclick="javascript:navigation_selectMenuItem('HOME');">
Home
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button active' id='nav_menu_button_search' onclick="javascript:navigation_selectMenuItem('search');">
Search & Browse
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_practice_areas' onclick="javascript:navigation_selectMenuItem('practice_areas');">
Practice Centers
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LITIGATION' onclick="javascript:navigation_selectMenuItem('LITIGATION');">
Litigation & Dockets
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_transactional' onclick="javascript:navigation_selectMenuItem('transactional');">
Transactional Law
</a>
</li>
<li class='' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_LEG_REG' onclick="javascript:navigation_selectMenuItem('LEG_REG');">
Legislative & Regulatory
</a>
</li>
<li class='legalAnalysis' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_news' onclick="javascript:navigation_selectMenuItem('news');">
Legal Analysis & News
</a>
</li>
<li class='last' id='nav_menu_button'>
<a class='nav_menu_button ' id='nav_menu_button_market' onclick="javascript:navigation_selectMenuItem('market');">
Companies & Markets
</a>
</li>

</ul>
</div>
<form accept-charset="UTF-8" action="/autocomplete/jump" id="search_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id='quicksearch_context' name='context_value' type='hidden' value='PRACTICE'>
<div class='searchBox' id='quick_search'>
<div class='inputContainer'>
<input autocomplete='off' id='quick_search_term' name='term' onkeydown='framework_handleTextInput(event,quick_search_term)' tabindex='2' type='text'>
<div class='searchButton' onmouseup='return framework_activateForm();' tabindex='3'></div>
<a href="/help/BLAWHelpSystem.htm#GO_Using_the_GO_BAR.htm" class="infoBtn" target="_blank" title="Using the &lt;GO&gt; Bar"></a>
<input id='quick_search_post' name='qs_type' type='hidden' value='general'>
<input id='quick_search_type' name='type' type='hidden' value='input_terms'>
<input id='quick_search_value' name='item_value' type='hidden'>
<input id='quick_search_origin' name='search_type' type='hidden' value='LAW'>
</div>
</div>
</form>


</div>
</div>

<div class='main clearfix'>
<div class='menuDrawer'>
<div class='interior'>
<div class='drawer_shade drawerShade clearfix'>
<div class='dropShadow'></div>
<div class='sub_menu subMenu' id='sub_menu_HOME'>
<table>
<tr>
<td class=''>
<ul>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_search'>
<div class='subTitles'>
<div class='subItem one '>
Search
</div>
<div class='subItem two '>
Specialized Searches
</div>
<div class='subItem one last'>
Browse
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/legal_search'>
<div class='navLinkTitle'>
All Legal Content
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Court Opinions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dnds_search'>
<div class='navLinkTitle'>
Domain Name Decisions
</div>
</a>
</li>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
News
</div>
</a>
</li>
<li>
<a class='clearfix' href='/patent_search'>
<div class='navLinkTitle'>
Patents
</div>
</a>
</li>
<li>
<a class='clearfix' href='/people_search'>
<div class='navLinkTitle'>
People
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Regulatory
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/no_action_search'>
<div class='navLinkTitle'>
SEC No-Action Letters
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_content_menu/105.293113'>
<div class='navLinkTitle'>
Federal Law
</div>
</a>
</li>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Law
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_practice_areas'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/antitrust'>
<div class='navLinkTitle'>
Antitrust
</div>
</a>
</li>
<li>
<a class='clearfix' href='/banking_finance'>
<div class='navLinkTitle'>
Banking & Finance
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/bankruptcy'>
<div class='navLinkTitle'>
Bankruptcy
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/corporate_ma'>
<div class='navLinkTitle'>
Corporate/M&A
</div>
</a>
</li>
<li>
<a class='clearfix' href='/employee_benefits'>
<div class='navLinkTitle'>
Employee Benefits
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/health'>
<div class='navLinkTitle'>
Health
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/ip_law'>
<div class='navLinkTitle'>
Intellectual Property
</div>
</a>
</li>
<li>
<a class='clearfix' href='/labor_employment'>
<div class='navLinkTitle'>
Labor & Employment
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/securities'>
<div class='navLinkTitle'>
Securities
</div>
</a>
</li>
<li>
<a class='clearfix' href='/tax'>
<div class='navLinkTitle'>
Tax
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LITIGATION'>
<div class='subTitles'>
<div class='subItem two '>
Litigation
</div>
<div class='subItem two last'>
Dockets
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/opinion_search'>
<div class='navLinkTitle'>
Search Court Opinions
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_menu/X7TO28O'>
<div class='navLinkTitle'>
BNA Outlines & Headnotes
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.103000'>
<div class='navLinkTitle'>
Federal Rules
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/general'>
<div class='navLinkTitle'>
Litigation Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/dockets'>
<div class='navLinkTitle'>
Search Dockets
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/breaking'>
<div class='navLinkTitle'>
Breaking Complaints
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/analytics'>
<div class='navLinkTitle'>
Docket Analytics
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dockets/coverage'>
<div class='navLinkTitle'>
Docket Coverage
</div>
</a>
</li>
<li>
<a class='clearfix' href='/dockets/requests'>
<div class='navLinkTitle'>
Docket Requests
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dockets/tracking'>
<div class='navLinkTitle'>
Docket Tracking
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_transactional'>
<div class='subTitles'>
<div class='subItem two '>
Search
</div>
<div class='subItem two last'>
Resources
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
EDGAR
</div>
</a>
</li>
<li>
<a class='clearfix' href='/clthreads/company-search-clc.php' target='_blank'>
<div class='navLinkTitle'>
EDGAR Comment Threads
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/example_and_saved_searches'>
<div class='navLinkTitle'>
Example Searches
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/dealmaker_document_search'>
<div class='navLinkTitle'>
DealMaker Documents
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/dealmaker_clause_search'>
<div class='navLinkTitle'>
DealMaker Clauses
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/deal_maker/current_awareness'>
<div class='navLinkTitle'>
Current Awareness
</div>
</a>
</li>
<li>
<a class='clearfix' href='/nav_menu/X7TS80O'>
<div class='navLinkTitle'>
Drafting Guides & Overviews
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_menu/X7TVS0O'>
<div class='navLinkTitle'>
Transactional Legal Treatises
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/deal_maker/resources'>
<div class='navLinkTitle'>
Transactional Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_LEG_REG'>
<div class='subTitles'>
<div class='subItem two '>
Legislative
</div>
<div class='subItem two last'>
Regulatory
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/leg_search'>
<div class='navLinkTitle'>
Search Legislative
</div>
</a>
</li>
<li>
<a class='clearfix' href='/leg_search/congressional_bill_search'>
<div class='navLinkTitle'>
Search Congressional Bills
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24221'>
<div class='navLinkTitle'>
U.S. Code
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Legislative Materials
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/leg_news_analysis'>
<div class='navLinkTitle'>
Legislative Resources
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/reg_search'>
<div class='navLinkTitle'>
Search Regulatory
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_search/federal_register_search'>
<div class='navLinkTitle'>
Search Federal Register
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_browser/105.24230'>
<div class='navLinkTitle'>
Code of Federal Regulations
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/map_nav/laws_regs'>
<div class='navLinkTitle'>
State Regulatory Materials
</div>
</a>
</li>
<li>
<a class='clearfix' href='/reg_updates'>
<div class='navLinkTitle'>
Monitor Regulators
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/reg_news_analysis'>
<div class='navLinkTitle'>
Regulatory Resources
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_news'>
<div class='subTitles'>
<div class='subItem two '>
Legal Analysis
</div>
<div class='subItem two last'>
News
</div>
<div class='clearfix'></div>
</div>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/law_reports'>
<div class='navLinkTitle'>
BNA Law Reports
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.456024'>
<div class='navLinkTitle'>
BNA Manuals
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/nav_content_menu/105.456026'>
<div class='navLinkTitle'>
BNA Portfolios
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/nav_content_menu/105.102923'>
<div class='navLinkTitle'>
Books & Treatises
</div>
</a>
</li>
</ul>
</td>
<td class='subNavGutter'></td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/news/advanced_search'>
<div class='navLinkTitle'>
Search News
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/news'>
<div class='navLinkTitle'>
Legal News
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li>
<a class='clearfix' href='/news/topic'>
<div class='navLinkTitle'>
News by Topic
</div>
</a>
</li>
<li>
<a class='clearfix' href='/news/top_news'>
<div class='navLinkTitle'>
TOP News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>
<div class='sub_menu subMenu' id='sub_menu_market'>
<table>
<tr>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/business_development'>
<div class='navLinkTitle'>
Business Development Center
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/edgar_search'>
<div class='navLinkTitle'>
Search EDGAR
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li>
<a class='clearfix' href='/company'>
<div class='navLinkTitle'>
Company Watchlist
</div>
</a>
</li>
<li class='last'>
<a class='clearfix' href='/company_search'>
<div class='navLinkTitle'>
Company Screener
</div>
</a>
</li>
</ul>
</td>
<td class='backgroundExtend'>
<ul>
<li class='last'>
<a class='clearfix' href='/report_writer'>
<div class='navLinkTitle'>
Company Report Writer
</div>
</a>
</li>
</ul>
</td>
<td class=''>
<ul>
<li class='last'>
<a class='clearfix' href='/market'>
<div class='navLinkTitle'>
Market News
</div>
</a>
</li>
</ul>
</td>
</tr>
</table>
</div>

</div>
</div>
<div class='bottomFlange'></div>
</div>
<div class='breadcrumbContainer printHide'>
<div class='breadHolder'>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_0'>
Search & Browse
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_1'>
<a href='/conversion/resolve_search/8f3051fbc9668851a43a791809511210'>
Court Opinions
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
<!-- .breadcrumb -->
<div class='breadcrumb' id='breadcrumb_2'>
<a href='/opinion_search/results/8f3051fbc9668851a43a791809511210'>
Search Results
</a>
</div>

<div class='breadcrumbDivider'>
/
</div>
</div>
</div>

</div>
<div class='page clearfix'>
<div class='content' id='page_content'>
<div id='statusHolder'></div>
<a name='primary_content'></a>
<div class='document_search_links_container printHide'>
<div class='prev_search_result_container'>
<div class='attachmentPanelBackButton' onclick="document.location = $('.prev_search_result_link a').attr('href')"></div>
<div class='prev_search_result_link'>
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1EIRO0N?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1EIRO0N">Previous Result: <span>Dev. Specialists, Inc. v. Akin Gump Stra...</span></a>
<div class='clearfix'></div>
</div>
</div>
<div class='next_search_result_container'>
<div class='next_search_result_link'>
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1I0EMM003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="{}" data-doc-id="X1I0EMM003">Next Result: <span>United States v. Tello, 687 F.3d 785 (7t...</span></a>
<div class='clearfix'></div>
</div>
<div class='attachmentPanelForwardButton' onclick="document.location = $('.next_search_result_link a').attr('href')"></div>
</div>
<div class='clearfix'></div>
</div>
<div class='clearfix'></div>

<div class='breadCrumbTitleRow clearfix eight grid'>
<div class="icon citation distinguished" title="Distinguished"></div>
<div class='title left' title='Borrome v. Attorney General, 687 F.3d 150 (3d Cir. 2012), Court Opinion'>
Borrome v. Attorney General, 687 F.3d 150 (3d Cir. 2012), Court Opinion
</div>
</div>

<div class='metadata' style='display: none'>
<div class='documentTitle'>Borrome v. Attorney General, 687 F.3d 150 (3d Cir. 2012), Court Opinion</div>
<div class='docId'>X1I0EME003</div>
<div class='docType'>OPINIONS</div>
<div class='case_name'>Borrome v. Attorney General</div>
<div class='displayCitation'>2012 BL 180446</div>
<div class='displayCitation'>687 F.3d 150</div>
<div class='displayCitation'>wkf3case:26221927</div>
</div>

<div class='search_outline_node_popup' style='display:none'>
<form accept-charset="UTF-8" action="/document/class_outline_search" id="search_document_node_form" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>Search</h2>
</div>
<p class='searchOver'>
Search over:
<span class='search_target_node'></span>
<input class="search_source_id" id="source_id" name="source_id" type="hidden" />
<input class="search_node_id" id="search_node_id" name="search_node_id" type="hidden" />
<input class="search_service_code" id="search_service_code" name="search_service_code" type="hidden" />
<input class="search_division" id="search_division" name="search_division" type="hidden" />
<input autocomplete="off" class="search_node_text" id="search_term" name="search_term" type="text" />
</p>
<div class='clearfix'></div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right print' onclick='this.form.submit();'>
<span>
Search
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

</div>
<div id='no_matching_keywords_popup' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>No Matches Found</h2>
</div>
<p>
Search term(s) not found.
</p>
<div class='popUpActions'>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>
<div id='copyWithCitationPopupContents' style='display:none'>
<div class='popupTitle clearfix'>
<div class='close' onclick='closePopup()'></div>
<h2>Copy with Citation</h2>
</div>
<p>
Copy the text below to paste into your document.
</p>
<div class='clearfix'>
<div class='copyWithCitationScrollBox'>
<div class='copyWithCitationArea left'>
<div class='copyWithCitationText'></div>
<div class='copyWithCitationDocumentTitle'></div>
</div>
<div class='ie9compat left'>
<img alt="" src="/images/transparency.png?1296705112" width="1" />
</div>
</div>
</div>
<div class='copyWithCitationCheckBoxHolder'>
<input checked="checked" class="linkCitation" id="link_citation" name="link_citation" onclick="updateCopyWithCitationLinks()" type="checkbox" value="true" />
Link citations to Bloomberg Law
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' onclick='closePopup();' type='button'>
<span>
Close
</span>
</button>
</div>
</div>

<script type='text/javascript'>
  //<![CDATA[
    $('#page_content').addClass("invisible");
  //]]>
</script>
<input id="doc_id" name="doc_id" type="hidden" value="X1I0EME003" />
<input id="hidden_document_title" name="hidden_document_title" type="hidden" value="Borrome v. Attorney General, 687 F.3d 150 (3d Cir. 2012), Court Opinion" />
<input id="hidden_case_name" name="hidden_case_name" type="hidden" value="Borrome v. Attorney General" />
<input id="hidden_case_docket" name="hidden_case_docket" type="hidden" />
<div class='toolHolder'>
<form accept-charset="UTF-8" action="" id="downloadPopupLinkForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div><input id="pde_location_type" name="pde_location_type" type="hidden" value="DOCUMENT" /><input id="full_doc_path" name="full_doc_path" type="hidden" value="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1I0EME003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="document_type" name="document_type" type="hidden" value="OPINIONS" /><input id="doc_id" name="doc_id" type="hidden" value="X1I0EME003&amp;search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="artifact_id" name="artifact_id" type="hidden" value="X1I0EME003" /><input id="title" name="title" type="hidden" value="Borrome v. Attorney General, 687 F.3d 150 (3d Cir. 2012), Court Opinion" /><input id="search32" name="search32" type="hidden" value="DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" /><input id="citation_analysis" name="citation_analysis" type="hidden" value="DISTINGUISHED" /><input id="context_resource_id" name="context_resource_id" type="hidden" value="8f3051fbc9668851a43a791809511210" /><input id="has_sidebar_info" name="has_sidebar_info" type="hidden" value="true" /><input id="tab_types_" name="tab_types[]" type="hidden" value="TAB_OPINION" /><input id="has_notepad" name="has_notepad" type="hidden" value="true" /><input id="notepad_id" name="notepad_id" type="hidden" value="X1I0EME003" /><input id="has_headnotes" name="has_headnotes" type="hidden" value="false" /><input id="preselect_option" name="preselect_option" type="hidden" value="DOCUMENT" /></form>

<ul class='tools printHide'>
<li>
<a href="#" onclick="javascript:quickPrintLink(); return false;">Quick Print</a>

</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('download','downloadPopupLinkForm'); return false;">Print/Download</a>
</li>
<li>
<a href="#" onclick="javascript:createFormPopupFromForm('email','downloadPopupLinkForm'); return false;">Email</a>
</li>
<li>
<a href="#" onclick="javascript:addPopupForm('add_to_workspace','?resource_path=%2Fs%2Fopinion%2F%38f%33%30%35%31fbc%39%36%36%38%38%35%31a%34%33a%37%39%31%38%30%39%35%31%31%32%31%30%2Fdocument%2FX%31I%30EME%30%30%33%3Fsearch%33%32%3DDPNLUQBDE%31FN%30Q%33IC%35PMASPT%36%34TJMSRPDPNMSUBDECUJ%32&amp;document_type=OPINIONS', null); return false;">+ Workspace</a>
</li>
<li>
<a onclick='javascript:PDETray_default.addSelection();'>
+ Queue
</a>
</li>
<li class='last'></li>
</ul>
</div>

<div class='bootstrap printHide tabs'>
<a class='borderTab activeTab' id='tab_DOCUMENT'>
Document
</a>

<a href="/s/opinion/8f3051fbc9668851a43a791809511210/bcite/X1I0EME003/history" class="borderTab inactiveTab" id="tab_HISTORY" onclick="docTabSpinner()">Direct History</a>

<a href="/s/opinion/8f3051fbc9668851a43a791809511210/bcite/X1I0EME003/analysis" class="borderTab inactiveTab" id="tab_ANALYSIS" onclick="docTabSpinner()">Case Analysis</a>

<a href="/s/opinion/8f3051fbc9668851a43a791809511210/bcite/X1I0EME003/toa" class="borderTab inactiveTab" id="tab_TOA" onclick="docTabSpinner()">Table of Authorities</a>

<a href="/s/opinion/8f3051fbc9668851a43a791809511210/related_content/X1I0EME003?search32=DPNLUQBDE1FN0Q3IC5PMASPT64TJMSRPDPNMSUBDECUJ2" class="borderTab inactiveTab" id="tab_CITING_DOCS" onclick="docTabSpinner()">Citing Documents</a>

<div class='showHide printHide'>
<div class='showHideSidebarArrow'>
<a class='bliderText' id='bliderLink'>
<span id='bliderText'>
Hide General Info & Notepad
</span>
<span id='notepadCountLabel'></span>
</a>
</div>
</div>

</div>

<!-- document -->
<script type='text/javascript'>
  //<![CDATA[
    var fluid_layout=false;
  //]]>
</script>

<!-- %table.markupContainment -->
<!-- %tbody -->
<!-- %tr -->
<!-- %td#markup_holder{:valign=>"top", :align=>"left"} -->
<div class='docHolder legal hasSearchTerms ' id='doc_holder'>
<div class='documentContent ' id='content_document'>


<script type="text/javascript">
					function Blaw__Citator()
					{
						window.location="bloomberg:bcite_url_prefix=/rest/documents/1718480207875";
					}
				</script><script type="text/javascript">
      var BLAW_TOTAL_KEYWORD = 0;
      var BLAW_CURRENT_KEYWORD = -1;
      var BLAW_LAST_COLOR = "yellow";
      var BLAW_ANCHOR_NAME = "blawkeyword";
      var BLAW_BASE_URL = document.location.href;

      function Blaw__changeCurElem(lastAnchor, newAnchor)
      {
        var baseUrl = Blaw__getBaseURL(document.location.href);
        document.location.href = baseUrl + "#" + newAnchor;
        var elem = document.getElementById(lastAnchor)[0];
        if (elem) {
          elem.style.backgroundColor = BLAW_LAST_COLOR;
        }
        elem = document.getElementById(newAnchor)[0];
        if (elem) {
          BLAW_LAST_COLOR = elem.style.backgroundColor;
          elem.style.backgroundColor = "orange";
        }
      }

      function Blaw__findNextKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (++BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }

        // if index does not exist on page continue to inc until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD < BLAW_TOTAL_KEYWORD) {
            ++BLAW_CURRENT_KEYWORD;
            // wrap around search, once only
            if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD && !looped) {
              BLAW_CURRENT_KEYWORD = 0;
              looped = true;
            }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findPrevKeyWord()
      {
        var looped = false;
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        if (--BLAW_CURRENT_KEYWORD < 0) {
          BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
          looped = true;
        }

        // if index does not exist on page continue to decr until one does
        while(document.getElementById(BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD).length == 0 && BLAW_CURRENT_KEYWORD >= 0) {
          --BLAW_CURRENT_KEYWORD;
          // wrap around search, once only
          if (BLAW_CURRENT_KEYWORD < 0 && !looped) {
            BLAW_CURRENT_KEYWORD = BLAW_TOTAL_KEYWORD - 1;
            looped = true;
          }
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__findNextFrom(indx)
      {
        var lastAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        BLAW_CURRENT_KEYWORD = indx;
        ++BLAW_CURRENT_KEYWORD;
        if (BLAW_CURRENT_KEYWORD >= BLAW_TOTAL_KEYWORD) {
          BLAW_CURRENT_KEYWORD = 0;
        }
        var newAnchor = BLAW_ANCHOR_NAME + BLAW_CURRENT_KEYWORD;
        Blaw__changeCurElem(lastAnchor, newAnchor);
      }

      function Blaw__getBaseURL(url)
      {
        var reg = new RegExp("(.+)#.+$");
        var ar = reg.exec(url);
        if (ar != null) {
          return ar[1];
        } else {
          return url;
        }
      }


    </script><div xmlns:fo="http://www.w3.org/1999/XSL/Format" class="metadata" style="display: none">
<div class="pagination_series_list">PrimaryFederalReporter,Bloomberg,</div>
<div class="citation-group">
<div class="cite" data-cite-type="PrimaryFederalReporter">687 F.3d 150</div>
<div class="cite" data-cite-type="DocketNumber">11-1975</div>
<div class="cite" data-cite-type="Bloomberg">2012 BL 180446</div>
</div>
</div>
<div align="left" class="tableofcontents">
<br CLEAR="right"><div class="page_text" style="float:right">
<b>Pagination</b><table class="page_legend" cellspacing="0">
<tr>
<td width="25%" align="left" valign="top">*</td>
<td width="50%" align="left" valign="top">F.3d </td>
</tr>
<tr>
<td width="25%" align="left" valign="top">**</td>
<td width="50%" align="left" valign="top">BL</td>
</tr>
</table>
</div>
<br>
</div>
<table><tbody><tr><td>&nbsp;</td></tr></tbody></table>
<p><center>
United States Court of Appeals, Third Circuit.
</center></p>
<hr align="center" width="65%">
<p><center>
Ramone BORROME, Petitioner v. ATTORNEY GENERAL OF the UNITED STATES,
Respondent.
</center></p>
<hr align="center" width="65%">
<p><center>
No. 11-1975.
</center></p>
<p><center>
Argued March 6, 2012.
</center></p>
<p><center>
Opinion filed: July 18, 2012.
</center></p>
<div id="para2" printdualcolumn="true"><p>
Appeal from the Board of Immigration Appeals (BIA) summarily affirming
Immigration Judge's (IJ), Andrew Arthur, Immigration Judge.
</p></div>
<span CLASS="page_no" data-cite="687 f 3d 151" data-cite-type="PrimaryFederalReporter" data-cite-pageno="151" data-primary-citation="687 F.3d 150">[*151]</span> <div id="para2" printdualcolumn="true"><p>
[EDITORS' NOTE: THIS PAGE CONTAINED HEADNOTES AND HEADNOTES ARE NOT AN
OFFICIAL PRODUCT OF THE COURT, THEREFORE THEY ARE NOT DISPLAYED.]
<span CLASS="page_no" data-cite="687 f 3d 152" data-cite-type="PrimaryFederalReporter" data-cite-pageno="152" data-primary-citation="687 F.3d 150">[*152]</span> 
</p></div>
<div id="para2" printdualcolumn="true"><p>
Thomas M. Griffin, Esq. [ARGUED], Surin &amp; Griffin, P.C., Philadelphia, PA,
for Petitioner.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Eric H. Holder, Jr., Attorney General, Anthony C. Payne, Senior Litigation
Counsel, Yedidya Cohen, Esq. [ARGUED], Thomas W. Hussey, Esq., Daniel I.
Smulow, Esq., United States Department of Justice, Office of Immigration
Litigation, Civil Division, Washington, DC, for Respondent.
</p></div>
<div id="para2" printdualcolumn="true"><p>
Before: SCIRICA, AMBRO, and VAN ANTWERPEN, Circuit Judges.
</p></div>
<div id="contentOpinion" printdualcolumn="true"><div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  OPINION OF THE COURT
</p></div></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  AMBRO, Circuit Judge.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This immigration case hinges on the relationship between prescription
"drugs" and "controlled substances." The Federal Food, Drug, and Cosmetic
Act ("FDCA"), 21 U.S.C. &sect; 301-399d, prohibits the unlicensed wholesale
distribution of prescription "drugs" in interstate commerce. <i>See</i>21 U.S.C. &sect;
331(t) &amp; 353(e)(2)(A). Similarly, the Controlled Substances Act ("CSA"),
21 U.S.C. &sect; 801-904, bans the unauthorized distribution of "controlled
substances." <i>See</i>21 U.S.C. &sect; 841(a). Some prescription "drugs" (like
Oxycontin) are also "controlled substances," but many (like Lipitor,
Zithromax, and thousands of other common medications) are not. Importantly,
the FDCA's wholesale distribution provisions make no distinction between
those prescription "drugs" that are "controlled substances" and those that
are not.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  With this background, we answer two questions. First, is a conviction for
violating the FDCA's wholesale distribution provisions an "aggravated
felony" &mdash; specifically "illicit trafficking in a controlled substance (as
defined in section 802 of Title 21), including a drug trafficking crime (as
defined in section 924(c) of Title 18)" &mdash;
<span CLASS="page_no" data-cite="687 f 3d 153" data-cite-type="PrimaryFederalReporter" data-cite-pageno="153" data-primary-citation="687 F.3d 150">[*153]</span> 
under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">8 U.S.C. &sect; 1101</a>(a)(43)(B) and <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(A)(iii)&amp;summary=yes#jcite">1227</a>(a)(2)(A)(iii)? Second, are these
FDCA provisions laws "relating to a controlled substance (as defined in
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976C2003?jcsearch=21%20U.S.C.%20%20802&amp;summary=yes#jcite">Section 802</a> of Title 21)" under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(B)(i)&amp;summary=yes#jcite">8 U.S.C. &sect; 1227</a>(a)(2)(B)(i)? Our answer to
both questions is no. Accordingly, we grant the petition for review,
reverse, and vacate the order of removal.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>I. Background</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Petitioner Ramone Borrome is a citizen of the Dominican Republic, and
since August 1996 has been a lawful permanent resident of the United States.
In May 2002, a Special Agent with the United States Food and Drug
Administration ("FDA") filed a criminal complaint against him and two other
men in federal court. The next month, a grand jury returned a two-count
indictment.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Count One charged the three defendants with having "unlawfully,
intentionally, and knowingly engaged in the unauthorized wholesale
distribution in interstate commerce of prescription drugs in violation of
[<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5MC003?jcsearch=21%20U.S.C.%20%20331(t)&amp;summary=yes#jcite">21 U.S.C. &sect; 331</a>(t) and <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)&amp;summary=yes#jcite">353</a>(e)], to wit, [Borrome, and his two
co-defendants] distributed the prescription drugs Combivir, Diflucan,
Oxycontin, Serostim, Viagra, Zerit, [and] Zyprexa without being licensed to
do so."<a HREF="#fn100" name="fnref_fn100">[fn1]</a> A.R. at 102 &para; 1. Count Two alleged a conspiracy. Significantly,
the indictment did not charge any of the three defendants <span CLASS="page_no" data-cite="2012 bl 180446 p 2" data-cite-type="Bloomberg" data-cite-pageno="2" data-primary-citation="">[**2]</span> with violating the
CSA. According to his judgment of conviction, Borrome pled guilty to Count
One while Count Two was dismissed on the Government's motion.<a HREF="#fn200" name="fnref_fn200">[fn2]</a> The
District Court sentenced him to four months' imprisonment followed by four
months' home confinement.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In June 2010, Borrome was served with a Notice to Appear for immigration
removal purposes. He filed a motion to terminate, which the Immigration
Judge ("IJ") denied.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In a written opinion, the IJ found Borrome removable under
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">8 U.S.C. &sect; 1101</a>(a)(43)(B) and <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(A)(iii)&amp;summary=yes#jcite">1227</a>(a)(2)(A)(iii) as an alien convicted of an
aggravated felony. The IJ concluded that the "hypothetical federal felony
test" required him to compare the FDCA's wholesale distribution provisions
to the CSA to determine whether Borrome's FDCA conviction is analogous to a
felony under the CSA. He noted that the CSA makes it a felony to distribute
knowingly or intentionally a controlled substance. <i>See</i>21 U.S.C. &sect; 841(a)(1)
&amp; <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976D8003?jcsearch=21%20U.S.C.%20%20841(b)(1)(C)&amp;summary=yes#jcite">(b)(1)(C)</a>. Turning to Borrome's indictment, he further noted that Borrome
pled guilty to distributing Oxycontin, which contains the Schedule II
controlled substance oxycodone. <i>See</i>21 C.F.R. &sect; 1308.12(b)(1)(xiii). (None of
the other six prescription "drugs" listed in Borrome's indictment contains
"controlled substances.") Thus, the IJ reasoned, "because [Borrome's]
offense involved the un-authorized distribution of a Schedule II controlled
substance," it is an aggravated felony under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">8 U.S.C. &sect; 1101</a>(a)(43)(B)
pursuant to the "hypothetical federal felony test." A.R. at 40.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The IJ also found Borrome removable under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(B)(i)&amp;summary=yes#jcite">8 U.S.C. &sect; 1227</a>(a)(2)(B)(i) as
an alien convicted of violating any law "relating to a controlled
substance." After reiterating the reference in Borrome's indictment to
Oxycontin, the IJ concluded that Borrome's conviction "is plainly a
violation
<span CLASS="page_no" data-cite="687 f 3d 154" data-cite-type="PrimaryFederalReporter" data-cite-pageno="154" data-primary-citation="687 F.3d 150">[*154]</span> 
of a law relating to a controlled substance." <i></i><cite>Id.at 42</cite>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In December 2010, the IJ ordered Borrome removed to the Dominican
Republic. In March 2011, on the Government's motion, the Board of
Immigration Appeals ("BIA") summarily affirmed the Us decision without
opinion pursuant to <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XU6260003?jcsearch=8%20C.F.R.%20%201003.1(e)(4)&amp;summary=yes#jcite">8 C.F.R. &sect; 1003.1</a>(e)(4). Borrome timely petitioned for
review. Before his counsel could file a motion to stay removal, he was
removed from the United States.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>II. Jurisdiction and Standard of Review</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The IJ had jurisdiction over Borrome's removal proceedings under
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10M003?jcsearch=8%20U.S.C.%20%201229a&amp;summary=yes#jcite">8 U.S.C. &sect; 1229a</a>. The BIA had jurisdiction to review the IJ's order of
removal and its underlying denial of Borrome's motion to terminate under
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XU6260003?jcsearch=8%20C.F.R.%20%201003.1(b)(3)&amp;summary=yes#jcite">8 C.F.R. &sect; 1003.1</a>(b)(3) and <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XU62IC003?jcsearch=8%20C.F.R.%20%201240.15&amp;summary=yes#jcite">1240.15</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We generally have jurisdiction under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH116003?jcsearch=8%20U.S.C.%20%201252&amp;summary=yes#jcite">8 U.S.C. &sect; 1252</a> to review final
orders of removal from the BIA. But <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH116003?jcsearch=8%20U.S.C.%20%201252(a)(2)(C)&amp;summary=yes#jcite">8 U.S.C. &sect; 1252</a>(a)(2)(C) provides that
"no court shall have jurisdiction to review any final order of removal
against an alien who is removable" under, among other provisions,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(A)(iii)&amp;summary=yes#jcite">8 U.S.C. &sect; 1227</a>(a)(2)(A)(iii) for having been convicted of an "aggravated
felony" or <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(B)(i)&amp;summary=yes#jcite">8 U.S.C. &sect; 1227</a>(a)(2)(B)(i) for having been convicted of
violating a law "relating to a controlled substance." We have jurisdiction,
however, to determine our jurisdiction. In other words, we have jurisdiction
to determine whether the necessary jurisdiction-stripping facts are present
in a particular case, specifically (1) whether the petitioner is an alien
and (2) whether he has been convicted of one of the enumerated offenses. <i>See</i>
<i>Papageorgiou v. Gonzales</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X12FVPQ003?jcsearch=413%20f%203d%20356&amp;summary=yes#jcite">413 F.3d 356</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X12FVPQ003?jcsearch=413%20f%203d%20356&amp;summary=yes#jcite">357-58</a> (3d Cir.2005); <span CLASS="page_no" data-cite="2012 bl 180446 p 3" data-cite-type="Bloomberg" data-cite-pageno="3" data-primary-citation="">[**3]</span> <i>Valansi v.</i>
<i>Ashcroft</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XACDFB?jcsearch=278%20f%203d%20203&amp;summary=yes#jcite">278 F.3d 203</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XACDFB?jcsearch=278%20f%203d%20203&amp;summary=yes#jcite">207</a> (3d Cir.2002). Furthermore, nothing in
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH116003?jcsearch=8%20usc%201252&amp;summary=yes#jcite">8 U.S.C. &sect; 1252</a>(a)(2)(C) precludes our review of questions of law presented
in a petition for review. <i>See</i>8 U.S.C. &sect; 1252(a)(2)(D).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  "When the BIA affirms an IJ's decision without opinion, we review the IJ's
decision as the final agency determination." <i>Konan v. Att'y Gen.</i>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X13TADA003?jcsearch=432%20f%203d%20497&amp;summary=yes#jcite">432 F.3d 497</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X13TADA003?jcsearch=432%20f%203d%20497&amp;summary=yes#jcite">500</a> (3d Cir.2005). We review <i>de novo</i>, without affording the
Attorney General deference under <i>Chevron, U.S.A., Inc. v. Natural Resources</i>
<i>Defense Council, Inc.</i>467 U.S. 837, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X5CAVA?jcsearch=104%20supreme%20court%202778&amp;summary=yes#jcite">104 S.Ct. 2778</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X5CAVA?jcsearch=81%20l%20ed%202d%20694&amp;summary=yes#jcite">81 L.Ed.2d 694</a> (1984),
the purely legal questions of whether a violation of particular federal
criminal statutes is an "aggravated felony" and whether those statutes are
laws "relating to a controlled substance." <i>See Denis v. Att'y Gen</i>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1ETG06003?jcsearch=633%20f%203d%20201&amp;summary=yes#jcite">633 F.3d 201</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1ETG06003?jcsearch=633%20f%203d%20201&amp;summary=yes#jcite">207-09</a> (3d Cir.2011); <i>Bobb v. Att'y Gen.</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X15FP4S003?jcsearch=458%20f%203d%20213&amp;summary=yes#jcite">458 F.3d 213</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X15FP4S003?jcsearch=458%20f%203d%20213&amp;summary=yes#jcite">217</a> n.
4 (3d Cir.2006); <i>Valansi</i>278 F.3d at 207-08.<a HREF="#fn300" name="fnref_fn300">[fn3]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <b>III. Analysis</b>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>A Removability Under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/1?citation=8%20usc%201101&amp;summary=yes#jcite">8 U.S.C. &sect; 1101</a>(a)(43)(B) and <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/1?citation=8%20usc%201227&amp;summary=yes#jcite">1227</a>(a)(2)(A)(iii):</i>
<i>Conviction for Committing an "Aggravated Felony</i>"
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  First, we must determine whether &mdash; as the IJ concluded &mdash; Borrome's
conviction
<span CLASS="page_no" data-cite="687 f 3d 155" data-cite-type="PrimaryFederalReporter" data-cite-pageno="155" data-primary-citation="687 F.3d 150">[*155]</span> 
for violating the FDCA's wholesale distribution provisions, <i>see</i>21 U.S.C. &sect;
331(t) &amp; 353(e)(2)(A), is an "aggravated felony" under
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">8 U.S.C. &sect; 1101</a>(a)(43)(B) and <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(A)(iii)&amp;summary=yes#jcite">1227</a>(a)(2)(A)(iii).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  "Any alien who is convicted of an aggravated felony at any time after
admission is deportable." 8 U.S.C. &sect; 122?(a)(2)(A)(iii). With respect to a
controlled substances offense, "aggravated felony" means "illicit
trafficking in a controlled substance (as defined in <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976C2003?jcsearch=21%20U.S.C.%20%20802&amp;summary=yes#jcite">section 802</a> of Title
`21) [the definitional section of the CSA], including a drug trafficking
crime (as defined in <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEHS54003?jcsearch=18%20U.S.C.%20%20924(c)&amp;summary=yes#jcite">section 924(c)</a> of Title 18)."
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">8 U.S.C. &sect; 1101</a>(a)(43)(B). "[T]he term `drug trafficking crime' means any
felony punishable under the Controlled Substances Act (<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976BU003?jcsearch=21%20U.S.C.%20801&amp;summary=yes#jcite">21 U.S.C. 801</a><i>et</i>
<i>seq.</i>), the Controlled Substances Import and Export Act (<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976H6003?jcsearch=21%20U.S.C.%20951&amp;summary=yes#jcite">21 U.S.C. 951</a><i>et</i>
<i>seq.</i>), or chapter 705 of title 46," which includes the maritime controlled
substances laws. <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEHS54003?jcsearch=18%20U.S.C.%20%20924(c)(2)&amp;summary=yes#jcite">18 U.S.C. &sect; 924</a>(c)(2).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We have held, however, that in addition to a <i>federal</i>felony conviction for
violating any of &sect; 924(c)(2)'s three statutes, a <i>state</i>controlled substances
conviction may also qualify as an "aggravated felony" under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">&sect;
1101(a)(43)(B)</a>. When presented with such a conviction, we have applied two
independent tests to determine whether the conviction is an "aggravated
felony": the "hypothetical federal felony" test and the "illicit trafficking
element" test. <i>See, e.g., Evanson v. Att'y Gen.</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1AA4UK003?jcsearch=550%20f%203d%20284&amp;summary=yes#jcite">550 F.3d 284</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1AA4UK003?jcsearch=550%20f%203d%20284&amp;summary=yes#jcite">288-90</a> (3d
Cir.2008); <i>Garcia v. Att'y Gen.</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X15K6BG003?jcsearch=462%20f%203d%20287&amp;summary=yes#jcite">462 F.3d 287</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X15K6BG003?jcsearch=462%20f%203d%20287&amp;summary=yes#jcite">291</a> (3d Cir.2006); <i>Gerbier v.</i>
<i>Holmes</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XACBFG?jcsearch=280%20f%203d%20297&amp;summary=yes#jcite">280 F.3d 297</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XACBFG?jcsearch=280%20f%203d%20297&amp;summary=yes#jcite">313</a> (3d Cir.2002). "Under the hypothetical federal
felony route, we compare the offense of conviction to the federal Controlled
Substances Act to determine if it is analogous to an offense under that
Act." <i>Evanson</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1AA4UK003?jcsearch=550%20f%203d%20284&amp;summary=yes#jcite">550 F.3d at 289</a>. "Under the illicit trafficking element test,
a state felony drug conviction constitutes an aggravated felony if it
contains a trafficking element." <i><a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1AA4UK003?jcsearch=550%20F.3d%20284&amp;summary=yes#jcite">Id</a>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  When applying either the "hypothetical federal felony" test or the
"illicit trafficking element" test under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">&sect; 1101(a)(43)(B)</a>, "and in making
aggravated felony determinations in general," we presumptively start our
analysis by applying the "formal categorical approach." <i>Garcia</i>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X15K6BG003?jcsearch=462%20f%203d%20287&amp;summary=yes#jcite">462 F.3d at 291</a>. Under this approach, we "`must look only to the statutory
definitions of the prior offenses,' and may not `consider other evidence
concerning the defendant's prior crimes,' including . . . `the particular
facts underlying [a] conviction[].'" <i><a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X15K6BG003?jcsearch=462%20F.3d%20287&amp;summary=yes#jcite">Id</a>.</i>(quoting <i>Singh</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XFPG73?jcsearch=383%20f%203d%20144&amp;summary=yes#jcite">383 F.3d at 147-48</a>)
(quoting <i>Taylor v. United States</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X5CBT9?jcsearch=495%20us%20575&amp;summary=yes#jcite">495 U.S. 575</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X5CBT9?jcsearch=495%20us%20575&amp;summary=yes#jcite">600</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/1?citation=110%20supreme%20court%202143&amp;summary=yes#jcite">110 S.Ct. 2143</a>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X5CBT9?jcsearch=109%20l%20ed%202d%20607&amp;summary=yes#jcite">109 L.Ed.2d 607</a> (1990)). There are two instances where we may depart from
the formal categorical <span CLASS="page_no" data-cite="2012 bl 180446 p 4" data-cite-type="Bloomberg" data-cite-pageno="4" data-primary-citation="">[**4]</span> approach when conducting an aggravated felony
analysis: (1) when "[c]onfronted with a disjunctive statute of conviction,
one in which there are alternative elements, . . . to determine which of the
alternative elements was the actual basis for the underlying conviction,"
<i>Evanson</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1AA4UK003?jcsearch=550%20f%203d%20284&amp;summary=yes#jcite">550 F.3d at 291</a>; <i>see also Garcia</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X15K6BG003?jcsearch=462%20f%203d%20287&amp;summary=yes#jcite">462 F.3d at 292</a>; <i>Singh</i>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XFPG73?jcsearch=383%20f%203d%20144&amp;summary=yes#jcite">383 F.3d at 162-63</a>; and (2) when "the language of a particular subsection of
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)&amp;summary=yes#jcite">&sect; 1101(a)(43)</a> &mdash; the aggravated felony enumerating statute &mdash; `invites inquiry
into the underlying facts of the case.'" <i>Evanson</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1AA4UK003?jcsearch=550%20f%203d%20284&amp;summary=yes#jcite">550 F.3d at 291-92</a>
(quoting <i>Nijhawan v. Att'y Gen.</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18SD9E003?jcsearch=523%20f%203d%20387&amp;summary=yes#jcite">523 F.3d 387</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18SD9E003?jcsearch=523%20f%203d%20387&amp;summary=yes#jcite">393</a> (3d Cir.2008)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>i. Can the "Hypothetical Federal Felony" Test Apply to a Conviction for</i>
<i>Violating Federal Law?</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As a preliminary matter, we must decide whether the "hypothetical federal
felony" test can apply to a conviction for violating a <i>federal</i>law, like the
FDCA, that is not one of the three federal controlled substances laws
enumerated in
<span CLASS="page_no" data-cite="687 f 3d 156" data-cite-type="PrimaryFederalReporter" data-cite-pageno="156" data-primary-citation="687 F.3d 150">[*156]</span> 
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEHS54003?jcsearch=18%20U.S.C.%20%20924(c)(2)&amp;summary=yes#jcite">&sect; 924(c)(2)</a> and incorporated in <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">&sect; 1101(a)(43)(B)</a>. We hold that it can.<a HREF="#fn400" name="fnref_fn400">[fn4]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As noted, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">&sect; 1101(a)(43)(B)</a> incorporates <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEHS54003?jcsearch=18%20U.S.C.%20%20924(c)(2)&amp;summary=yes#jcite">&sect; 924(c)(2)</a>, which defines a "drug
trafficking crime" as "any felony <i>punishable under</i>" the CSA, the Controlled
Substances Import and Export Act, or the maritime controlled substances
laws. <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEHS54003?jcsearch=18%20U.S.C.%20%20924(c)(2)&amp;summary=yes#jcite">18 U.S.C. &sect; 924</a>(c)(2) (emphasis added). In this statute, "Congress
referred to felonies `punishable under[,]' not `convictions obtained
under[,]'" the three enumerated statutes. <i>Gerbier</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XACBFG?jcsearch=280%20f%203d%20297&amp;summary=yes#jcite">280 F.3d at 304</a> (quoting
<i>Matter of Barrett</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X12K1MA003?jcsearch=20%20immigration%20and%20nationality%20decisions%20171&amp;summary=yes#jcite">20 I. &amp; N. Dec. 171</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X12K1MA003?jcsearch=20%20immigration%20and%20nationality%20decisions%20171&amp;summary=yes#jcite">175</a> (BIA 1990)). Therefore, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEHS54003?jcsearch=18%20U.S.C.%20%20924(c)(2)&amp;summary=yes#jcite">&sect;
924(c)(2)</a> does not require an actual conviction under one of its three laws.
<i><a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XACBFG?jcsearch=280%20F.3d%20297&amp;summary=yes#jcite">Id</a>.</i>A conviction that is hypothetical[] punishable as a felony under one of &sect;
924(c)(2)'s three statutes can also qualify as a "drug trafficking crime."
<i></i><a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XACBFG?jcsearch=280%20F.3d%20297&amp;summary=yes#jcite">Id.at 305, 312</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Thus far the BIA and our Court have applied this "hypothetical federal
felony" test only to convictions for violating state controlled substances
laws. <i>See, e.g., Evanson</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1AA4UK003?jcsearch=550%20f%203d%20284&amp;summary=yes#jcite">550 F.3d at 289-293</a>; <i>Garcia</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X15K6BG003?jcsearch=462%20f%203d%20287&amp;summary=yes#jcite">462 F.3d at 292-93</a>;
<i>Gerbier</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XACBFG?jcsearch=280%20f%203d%20297&amp;summary=yes#jcite">280 F.3d at 308-11</a>; <i>Matter of Davis</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X12K1PE003?jcsearch=20%20immigration%20and%20nationality%20decisions%20536&amp;summary=yes#jcite">20 I. &amp; N. Dec. 536</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X12K1PE003?jcsearch=20%20immigration%20and%20nationality%20decisions%20536&amp;summary=yes#jcite">541</a> (BIA
1992). Ordinarily when an alien is convicted of violating a federal
controlled substances law, he is convicted under the CSA. In those cases,
there is no need for the hypothetical federal felony test because <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEHS54003?jcsearch=18%20U.S.C.%20%20924(c)(2)&amp;summary=yes#jcite">&sect;
924(c)(2)</a> makes an <i>actual</i>federal felony conviction under the CSA a "drug
trafficking crime," and thus, via <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">&sect; 1101(a)(43)(B)</a>, an "aggravated felony."
But in this case the Government argues that the FDCA's wholesale
distribution laws create the same bases for removability as <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEHS54003?jcsearch=18%20U.S.C.%20%20924(c)(2)&amp;summary=yes#jcite">&sect; 924(c)(2)</a>'s
three controlled substances laws.<a HREF="#fn500" name="fnref_fn500">[fn5]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Notwithstanding the unusual circumstances of this case, we conclude that
the "hypothetical federal felony" test can apply to a conviction for
violating a federal law other than those enumerated in &sect; 924(c)(2). There is
nothing in the text of either <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">&sect; 1101(a)(43)(B)</a> or <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEHS54003?jcsearch=18%20U.S.C.%20%20924(c)(2)&amp;summary=yes#jcite">&sect; 924(c)(2)</a> that limits
application of the "hypothetical federal felony" test to state controlled
substances convictions. In fact, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)&amp;summary=yes#jcite">&sect; 1101(a)(43)</a> specifically indicates that
the term "aggravated felony" applies to an offense "whether
<span CLASS="page_no" data-cite="687 f 3d 157" data-cite-type="PrimaryFederalReporter" data-cite-pageno="157" data-primary-citation="687 F.3d 150">[*157]</span> 
in violation of Federal or State law." When applying the test, the key
inquiry is simply whether the alien's conviction is hypothetically
punishable as a felony under any of the three controlled substances laws
listed in <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEHS54003?jcsearch=18%20U.S.C.%20%20924(c)(2)&amp;summary=yes#jcite">&sect; 924(c)(2)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>ii. Does Borrome's FDCA Conviction Meet the "Hypothetical Federal Felony"</i>
<i>Test?</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Having determined that the "hypothetical federal felony" test can apply in
this case, we turn to whether it is met. To do so, we first consider <span CLASS="page_no" data-cite="2012 bl 180446 p 5" data-cite-type="Bloomberg" data-cite-pageno="5" data-primary-citation="">[**5]</span> whether
the presumption in favor of the categorical approach applies to our
analysis. It is well established that the aggravated felony enumerating
statute at issue here, &sect; 1103(a)(43)(B), does not permit departure from the
categorical approach nor does it invite inquiry into the underlying facts of
a conviction. <i>See Evanson</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1AA4UK003?jcsearch=550%20f%203d%20284&amp;summary=yes#jcite">550 F.3d at 292</a>;" <i>Garcia</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X15K6BG003?jcsearch=462%20f%203d%20287&amp;summary=yes#jcite">462 F.3d at 292</a>. If we
were to depart from the categorical approach, we would have to find
justification for that departure in Borrome's statutes of conviction. We
conclude, however, that the FDCA's wholesale distribution statutes,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5MC003?jcsearch=21%20U.S.C.%20%20331(t)&amp;summary=yes#jcite">21 U.S.C. &sect; 331</a>(t) and <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)(2)(A)&amp;summary=yes#jcite">353</a>(e)(2)(A), do not permit departure from the formal
categorical approach because they are not "disjunctive" statutes that define
distinct offenses. They are instead a single offense that is not
categorically "punishable under" any of &sect; 924(c)(2)'s three controlled
substances statutes. Therefore, a conviction under these FDCA. provisions
fails the "hypothetical federal felony" test.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We begin by unraveling what Borrome's statutes of conviction,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5MC003?jcsearch=21%20U.S.C.%20%20331(t)&amp;summary=yes#jcite">21 U.S.C. &sect; 331</a> (t) and <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)&amp;summary=yes#jcite">353</a>(e), actually prohibit. In pertinent part, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5MC003?jcsearch=21%20U.S.C.%20%20331(t)&amp;summary=yes#jcite">&sect;
331(t)</a> prohibits "the distribution of drugs in violation of <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)&amp;summary=yes#jcite">section 353(e)</a>
of this title."<a HREF="#fn600" name="fnref_fn600">[fn6]</a> <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)(2)(A)&amp;summary=yes#jcite">Section 353(e)(2)(A)</a>, in turn, provides that "[n]o
person may engage in the wholesale distribution in interstate commerce of
drugs subject to <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(b)&amp;summary=yes#jcite">subsection (b)</a> of this section in a State unless such
person is licensed by the State in accordance with the guidelines issued
under subparagraph (B)." "The term `wholesale distribution' means
distribution of drugs subject to sub-section (b) of this section to other
than the consumer or patient," with some exceptions not relevant here.
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)(3)(B)&amp;summary=yes#jcite">21 U.S.C. &sect; 353</a>(e)(3)(B). <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(b)(1)&amp;summary=yes#jcite">Section 353(b)(1)</a> &mdash; the relevant part of the
"<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(b)&amp;summary=yes#jcite">subsection (b)</a> of this section" to" which <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)(2)(A)&amp;summary=yes#jcite">&sect; 353(e)(2)(A)</a> <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)(3)(B)&amp;summary=yes#jcite">and 353(e)(3)(B)</a>
refer &mdash; subjects to certain prescription requirements
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      [a] drug intended for use by a man which (A) because of its
    toxicity or other potentiality for harmful effect, or the method of
    its use, or the collateral measures necessary to its use, is not
    safe for use except under the supervision of a practitioner licensed
    by law to administer such drug; or (B) is limited by an approved
    application under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OQ003?jcsearch=21%20U.S.C.%20%20355&amp;summary=yes#jcite">section 355</a> of this title to use under the
    professional supervision of a practitioner licensed by law to
    administer such drug.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
For simplicity, these are called prescription drugs.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(b)(1)&amp;summary=yes#jcite">Section 353(b)(1)</a> does not provide a list of specific drugs subject to its
prescription
<span CLASS="page_no" data-cite="687 f 3d 158" data-cite-type="PrimaryFederalReporter" data-cite-pageno="158" data-primary-citation="687 F.3d 150">[*158]</span> 
requirements. Whether a drug is a prescription drug by virtue of <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(b)(1)(A)&amp;summary=yes#jcite">&sect;
353(b)(1)(A)</a> is a question of fact for the jury. <i>See United States v. Munoz</i>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X13KD3M003?jcsearch=430%20f%203d%201357&amp;summary=yes#jcite">430 F.3d 1357</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X13KD3M003?jcsearch=430%20f%203d%201357&amp;summary=yes#jcite">1367</a> (11th Cir.2005). The FDA does, however, publish in what
is colloquially known as the "Orange Book" a list of what are prescription
drugs by virtue of <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(b)(1)(B)&amp;summary=yes#jcite">&sect; 353(b)(1)(B)</a> because they are "limited by an approved
application under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OQ003?jcsearch=21%20U.S.C.%20%20355&amp;summary=yes#jcite">section 355</a> of [title 21] to use under the professional
supervision of a practitioner licensed by law to administer such drug." <i>See</i>
<i>U.S. Food &amp; Drug Admin., U.S. Dep't of Health &amp; Human Servs., Approved Drug</i>
<i>Products with Therapeutic Equivalence Evaluations</i>3-1 to 3-424 (32d ed.
2012), <i>available at http://www.fda.gov/downloads/Drugs/Development Approval</i>
<i>Process/UCM 071436.pdf</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The term "controlled substance" appears nowhere in &sect; 331(t) and 353(e). A
"controlled substance" is defined in the CSA to mean "a drug or other
substance, or immediate precursor, included in schedule I, II, III, <span CLASS="page_no" data-cite="2012 bl 180446 p 6" data-cite-type="Bloomberg" data-cite-pageno="6" data-primary-citation="">[**6]</span> IV, or V
of part B of this subchapter." <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976C2003?jcsearch=21%20U.S.C.%20%20802(6)&amp;summary=yes#jcite">21 U.S.C. &sect; 802</a>(6). A list of "controlled
substances" is provided in <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976CA003?jcsearch=21%20usc%20812&amp;summary=yes#jcite">21 U.S.C. &sect; 812</a> and supplemented by
21 C.F.R. &sect; 1308.11-.15. The only way to discern an overlap between
prescription drugs and controlled substances is to compare the list of
prescription drugs in the FDA's Orange Book and the list of controlled
substances in the CSA and its corresponding regulations. When doing so, it
is clear that, while some prescription drugs contain chemicals that are also
regulated as "controlled substances" under the CSA, many do not. For
example, Oxycontin &mdash; one of the seven drugs listed in Borrome's indictment &mdash;
is a prescription drug, <i>see Approved Drug Products with Therapeutic</i>
<i>Equivalence Evaluations, supra</i>, at 3-324, and it contains the "controlled
substance" oxycodone, <i>see</i>21 C.F.R. &sect; 1308.12(b)(1)(xiii). In contrast,
Viagra &mdash; another of the seven drugs listed in Borrome's indictment[]-is a
prescription drug, <i>see Approved Drug Products with Therapeutic Equivalence</i>
<i>Evaluations</i>at 3-371, but it does not contain a "controlled substance."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Although some prescription drugs do contain controlled substances, &sect;
331(t) and 353(e)(2)(A) make no distinction between convictions involving
prescriptions drugs that do contain controlled substances and those that do
not. In other words, under &sect; 331(t) and 353(e)(2)(A), a conviction for the
unlicensed wholesale distribution of Viagra is no different than a
conviction for the unlicensed wholesale distribution of Oxycontin.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  This is the pivot point for our "hypothetical federal felony" analysis.
When making aggravated felony determinations under &sect; 1101(a)(43)(B), "[w]e
must rely only on Vhat the convicting court must necessarily have found to
support the conviction.'" <i>Jeune v. Att'y Gen.</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X16AKPI003?jcsearch=476%20f%203d%20199&amp;summary=yes#jcite">476 F.3d 199</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X16AKPI003?jcsearch=476%20f%203d%20199&amp;summary=yes#jcite">205</a> (3d
Cir.2007) (quoting <i>Steele v. Blackman</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X50C80?jcsearch=236%20f%203d%20130&amp;summary=yes#jcite">236 F.3d 130</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X50C80?jcsearch=236%20f%203d%20130&amp;summary=yes#jcite">135</a> (3d Cir.2001)).
When Borrome pled guilty to violating the FDCA's wholesale distribution
provisions, the convicting court did not necessarily have to find whether
the prescriptions drugs involved also contained controlled substances. Such
a finding would be irrelevant under &sect; 331(t) and 353(e)(2)(A) because those
statutes define a single offense, not separate and distinct offenses.
Therefore, &sect; 331(t) and 353(e)(2)(A) do not permit departure from the formal
categorical approach.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  When we apply the categorical approach, we see daylight between the
elements of a CSA controlled substances distribution conviction and an FDCA
prescription drug distribution conviction. Under the CSA, it is unlawful to
"knowingly or intentionally . . . distribute . . . a
<span CLASS="page_no" data-cite="687 f 3d 159" data-cite-type="PrimaryFederalReporter" data-cite-pageno="159" data-primary-citation="687 F.3d 150">[*159]</span> 
controlled substance." <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976D8003?jcsearch=21%20U.S.C.%20%20841(a)(1)&amp;summary=yes#jcite">21 U.S.C. &sect; 841</a>(a)(1). Under the FDCA, it is unlawful
to "engage in the wholesale distribution in interstate commerce of
[prescription] drugs" without a proper license. <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)(2)(A)&amp;summary=yes#jcite">21 U.S.C. &sect; 353</a>(e)(2)(A). As
our discussion above demonstrates, prescription drugs and controlled
substances do not always go hand-in-hand. If the Government successfully
proves the elements for a conviction under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)(2)(A)&amp;summary=yes#jcite">21 U.S.C. &sect; 353</a>(e)(2)(A), it does
not necessarily prove the elements for a conviction under
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976D8003?jcsearch=21%20U.S.C.%20%20841(a)(1)&amp;summary=yes#jcite">21 U.S.C. &sect; 841</a>(a)(1). Because a conviction under the FDCA for the
unlicensed wholesale distribution of prescription drugs is not categorically
"punishable under" the CSA or &sect; 924(c)(2)'s other controlled substances
laws, Borrome's conviction fails the "hypothetical federal <span CLASS="page_no" data-cite="2012 bl 180446 p 7" data-cite-type="Bloomberg" data-cite-pageno="7" data-primary-citation="">[**7]</span> felony test."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>iii The "Illicit Trafficking" Element Test</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Neither the Government before us, nor the IJ, contends that Borrome's
conviction meets the "illicit trafficking element" test. That test requires
that a felony contain a "trafficking element," meaning "the unlawful trading
or dealing of a controlled substance." <i>Jeune</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X16AKPI003?jcsearch=476%20f%203d%20199&amp;summary=yes#jcite">476 F.3d at 202</a> (quoting
<i>Gerbier</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XACBFG?jcsearch=280%20f%203d%20297&amp;summary=yes#jcite">280 F.3d at 305</a>). Because, as discussed above, &sect; 331(t) and
353(e)(2)(A) do not permit departure from the categorical approach and they
do not require the distribution of a controlled substance, they must
necessarily fail the "illicit trafficking element" test as well.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  <i>B. Removability Under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/1?citation=8%20usc%201227&amp;summary=yes#jcite">8 U.S.C. &sect; 1227</a>(a)(2)(B)(i): Conviction for</i>
<i>Violating Any Law "Relating to a Controlled Substance</i>"
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Next, we consider whether Borrome was removable under
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(B)(i)&amp;summary=yes#jcite">8 U.S.C. &sect; 1227</a>(a)(2)(B)(i). That section of the Immigration and Nationality
Act ("INA"), <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101&amp;summary=yes#jcite">8 U.S.C. &sect; 1101</a>-<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH1BC003?jcsearch=8%20U.S.C.%20%201537&amp;summary=yes#jcite">1537</a>, provides that:
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      Any alien who at any time after admission has been convicted of a
    violation of (or a conspiracy or attempt to violate) <i>any law or</i>
    <i>regulation</i>of a State, the United States, or a foreign country
    <i>relating to a controlled substance</i>(as defined in <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976C2003?jcsearch=21%20U.S.C.%20%20802&amp;summary=yes#jcite">section 802</a> of
    Title 21), other than a single offense involving possession for
    one's own use of 30 grams or less of marijuana, is deportable.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
(Emphases added.)
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Unless an alien claims that the basis of his alleged removability is "a
single offense involving possession for one's own use of 30 grams or less of
marijuana," <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(B)(i)&amp;summary=yes#jcite">&sect; 1227(a)(2)(B)(i)</a> does not ask courts to scour an alien's
indictment and sniff out a controlled substance, or otherwise to look to the
underlying facts of an alien's conviction, to determine whether the alien is
removable. Such an inquiry would be irrelevant. The important statutory
phrase is "relating to a controlled substance," and it modifies "law or
regulation." <i>See Mielewczyk v. Holder</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1BEBCO003?jcsearch=575%20f%203d%20992&amp;summary=yes#jcite">575 F.3d 992</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1BEBCO003?jcsearch=575%20f%203d%20992&amp;summary=yes#jcite">994</a> (9th Cir.2009); <i>see</i>
<i>also Mizrahi v. Gonzales</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X177R4C003?jcsearch=492%20f%203d%20156&amp;summary=yes#jcite">492 F.3d 156</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X177R4C003?jcsearch=492%20f%203d%20156&amp;summary=yes#jcite">159</a> (2d Cir.2007) (noting that
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X7FGTO003?jcsearch=8%20U.S.C.%20%201182(a)(2)(A)(i)(II)&amp;summary=yes#jcite">8 U.S.C. &sect; 1182</a>(a)(2)(A)(i)(II), which is the inadmissibility counterpart to
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(B)(i)&amp;summary=yes#jcite">8 U.S.C. &sect; 1227</a>(a)(2)(B)(i), "applies only if the `law or regulation'
violated relates to controlled substances"). Ah analysis of the laws or
regulations of conviction is required. Therefore, our task is to determine
whether the FDCA's wholesale distribution provisions, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5MC003?jcsearch=21%20U.S.C.%20%20331(t)&amp;summary=yes#jcite">21 U.S.C. &sect; 331</a>(t) and
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)(2)(A)&amp;summary=yes#jcite">353</a>(e)(2)(A), are laws "relating to a controlled substance," not (as the IJ
seems to have believed) whether the facts of Borrome's conviction "relat[e]
to a controlled substance."<a HREF="#fn700" name="fnref_fn700">[fn7]</a>
<span CLASS="page_no" data-cite="687 f 3d 160" data-cite-type="PrimaryFederalReporter" data-cite-pageno="160" data-primary-citation="687 F.3d 150">[*160]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The INA does not define the phrase "relating to." But the BIA has
interpreted it expansively: "[t]he `relating to' concept has a broad
ordinary meaning, namely, `to stand in some relation; to have bearing or
concern; to pertain; refer; to bring into association with or connection
with.'" <i>Matter of Espinoza</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1C2RCM003?jcsearch=25%20immigration%20and%20nationality%20decisions%20118&amp;summary=yes#jcite">25 I. &amp; N. Dec. 118</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1C2RCM003?jcsearch=25%20immigration%20and%20nationality%20decisions%20118&amp;summary=yes#jcite">120</a> (BIA 2009) (quoting
Black's Law Dictionary 1158 (5th ed. 1979) (other quotation marks omitted));
<i>see also Matter of Beltran</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X12K1PA003?jcsearch=20%20immigration%20and%20nationality%20decisions%20521&amp;summary=yes#jcite">20 I. &amp; N. Dec. 521</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X12K1PA003?jcsearch=20%20immigration%20and%20nationality%20decisions%20521&amp;summary=yes#jcite">526</a> (BIA 1992) ("The phrase
`relating to' . . . has long been construed to have broad coverage."). The
Supreme Court, when interpreting the phrase "relating to" in the Airline
Deregulation Act, has also adopted the broad Black's Law Dictionary
definition. <i>See Morales v. Trans World Airlines, Inc.</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X5CC5P?jcsearch=504%20us%20374&amp;summary=yes#jcite">504 U.S. 374</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X5CC5P?jcsearch=504%20us%20374&amp;summary=yes#jcite">383</a>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/1?citation=112%20supreme%20court%202031&amp;summary=yes#jcite">112 S.Ct. 2031</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X5CC5P?jcsearch=119%20l%20ed%202d%20157&amp;summary=yes#jcite">119 L.Ed.2d 157</a> (1992) (quoting Black's Law Dictionary 1158
(5th ed. 1979)).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We too have explained, in the context of another provision of the INA,
that the phrase "relating <span CLASS="page_no" data-cite="2012 bl 180446 p 8" data-cite-type="Bloomberg" data-cite-pageno="8" data-primary-citation="">[**8]</span> to" is "to be read expansively[,] and `must not be
strictly confined to its narrowest meaning.'" <i>Denis</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1ETG06003?jcsearch=633%20f%203d%20201&amp;summary=yes#jcite">633 F.3d at 209</a>
(quoting <i>Drakes v. Zimski</i>240 F.3d 246, 249 (3d Cir.2001)). As we have said,
"[t]he term `relate' means `to show or establish a logical or causal
connection between.'" <i>Bobb</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X15FP4S003?jcsearch=458%20f%203d%20213&amp;summary=yes#jcite">458 F.3d at 219</a> (quoting Webster's Third New
International Dictionary (Unabridged) 1916 (1991)). Other Courts of Appeals
have given the phrase similarly broad readings. <i>See Mielewczyk</i>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1BEBCO003?jcsearch=575%20f%203d%20992&amp;summary=yes#jcite">575 F.3d at 994-95</a> (quoting Webster's dictionary definition with approval);
<i>Desai v. Mukasey</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18MLIC003?jcsearch=520%20f%203d%20762&amp;summary=yes#jcite">520 F.3d 762</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18MLIC003?jcsearch=520%20f%203d%20762&amp;summary=yes#jcite">764</a> (7th Cir.2008) (same).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  As the breadth of the phrase "relating to" suggests, a law need not
require for its violation the actual involvement of a controlled substance
in order to "relat[e] to" a controlled substance. "If Congress wanted a
one-to-one correspondence between the [laws of conviction] and the federal
CSA, it would have used a word like `involving' instead of `relating to,' or
it could have written the statute the way that it wrote <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH0TC003?jcsearch=8%20U.S.C.%20%201101(a)(43)(B)&amp;summary=yes#jcite">&sect; 1101(a)(43)(B)</a>
[the aggravated felony controlled substances statute]." <i>Desai</i>520 F.3d at
766.<a HREF="#fn800" name="fnref_fn800">[fn8]</a>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In this vein, the BIA and several of our sister Courts of Appeals have
held that a law prohibiting the possession or use of drug paraphernalia is a
law "relating to a controlled substance." <i>See Matter of Espinoza</i>, 25 I, &amp; N.
Dec. at 118; <i>see also Alvarez Acosta v. Att'y Gen.</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18PJNG003?jcsearch=524%20f%203d%201191&amp;summary=yes#jcite">524 F.3d 1191</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18PJNG003?jcsearch=524%20f%203d%201191&amp;summary=yes#jcite">1196</a>
(11th Cir.2008); <i>Escobar Barraza v. Mukasey</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18KNBE003?jcsearch=519%20f%203d%20388&amp;summary=yes#jcite">519 F.3d 388</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18KNBE003?jcsearch=519%20f%203d%20388&amp;summary=yes#jcite">390-91</a> (7th
Cir.2008); <i>Luu-Le v. I.N.S.</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X3FK12?jcsearch=224%20f%203d%20911&amp;summary=yes#jcite">224 F.3d 911</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X3FK12?jcsearch=224%20f%203d%20911&amp;summary=yes#jcite">914-16</a> (9th Cir.2000).
Paraphernalia statutes relate to controlled substances, even though they
prohibit the possession of instruments rather than controlled substances
themselves, because "the possession of an item intentionally used for
manufacturing, using, testing, or enhancing the effect of a controlled
substance necessarily pertains to a controlled substance." <i>Espinoza</i>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1C2RCM003?jcsearch=25%20I.%20%26%20N.%20Dec.%20at%20118&amp;summary=yes#jcite">25 I. &amp; N. Dec. at 120</a>. The Ninth Circuit has reached this conclusion
notwithstanding that the definition of the term "drug" as used in the
California drug paraphernalia statute "does not map perfectly" with the
definition of "controlled substance" under the CSA. <i>See Lutir-Le, 22A</i>F.3d at
915.
<span CLASS="page_no" data-cite="687 f 3d 161" data-cite-type="PrimaryFederalReporter" data-cite-pageno="161" data-primary-citation="687 F.3d 150">[*161]</span> 
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Similarly, the Seventh Circuit has held that a statute prohibiting the
unlawful delivery of a "Look-Alike Substance" is a law "relating to a
controlled substance." <i>Desai</i>520 F.3d at 764-66. The defendant in that case
was convicted of selling chocolates purporting to contain, but not actually
containing, the hallucinogenic controlled substance Psilocybin. <i></i><a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18MLIC003?jcsearch=520%20F.3d%20762&amp;summary=yes#jcite">Id.at 763</a>.
He was charged under Illinois law with the unlawful delivery of a
"Look-Alike Substance," defined as a substance which (1) by its identifying
physical characteristics "would lead a reasonable person to believe that the
substance is a controlled substance, or (2) is expressly or impliedly
represented to be a controlled substance or is distributed under
circumstances which would lead a reasonable person to believe that the
substance is a controlled substance." <i></i><a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18MLIC003?jcsearch=520%20F.3d%20762&amp;summary=yes#jcite">Id.at 764-65</a> (quoting 720 111. Comp.
Stat. 570/102(y)). The Court explained that the state law is one "related
to" a federal controlled substance because distributing something that would
lead one to believe it contained a federal controlled substance brings the
state law "into association with a federal controlled substance." <i></i><a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18MLIC003?jcsearch=520%20F.3d%20762&amp;summary=yes#jcite">Id.at 765</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
      It is the fact that there is a relation between the Look-Alike and
    the <span CLASS="page_no" data-cite="2012 bl 180446 p 9" data-cite-type="Bloomberg" data-cite-pageno="9" data-primary-citation="">[**9]</span> controlled substance that justifies making the distribution of
    the Look-Alike illegal. To put it more bluntly, the idea of
    distributing a "Psilocybin Look-Alike" would not even exist as a
    legal (or linguistic) concept without its connection to, or
    relationship with, Psilocybin. The simulacrum and the thing itself
    are always connected.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<i><a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18MLIC003?jcsearch=520%20F.3d%20762&amp;summary=yes#jcite">Id</a>.</i>Therefore, according to the Seventh Circuit, the law relates to a
controlled substance, notwithstanding that a "Look-Alike" itself is not a
"controlled substance," as there is "enough of a relation to the federal
controlled substance to warrant removal from the United States for violating
the law." <i></i><a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X18MLIC003?jcsearch=520%20F.3d%20762&amp;summary=yes#jcite">Id.at 766</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  The drug paraphernalia cases and the Seventh Circuit's decision in
<i>Desai</i>convince us that the phrase "any law . . . relating to a controlled
substance" reaches those laws that do not require the actual involvement of
a controlled substance for a conviction. But we are equally convinced that a
law does not automatically come within the ambit of that phrase simply
because a conviction <i>may</i>involve a controlled substance. Another section of
the FDCA provides a <i>reduction ad absurdum.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(d)(3)(B)&amp;summary=yes#jcite">21 U.S.C. &sect; 353</a>(d)(3)(B), "[d]rug manufacturers or authorized
distributors of record shall store drug samples under conditions that will
maintain their stability, integrity, and effectiveness and will assure that
the drug samples will be free of contamination, deterioration, and
adulteration" when distributing the drug samples (unless they use mail or
common carrier). Distributing drug samples in violation of <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(d)&amp;summary=yes#jcite">&sect; 353(d)</a>, or
otherwise failing to comply with its requirements, is punishable by not more
than one year imprisonment, a $1,000 fine, or both. <i>See</i>21 U.S.C. &sect; 331(t) &amp;
333(a). If we were to give the phrase "relating to" a boundless
interpretation, we might conclude that <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(d)(3)(B)&amp;summary=yes#jcite">&sect; 353(d)(3)(B)</a> is a law "relating to"
a controlled substance because it regulates some chemicals that also happen
to contain "controlled substances." It would be difficult to accept,
however, that a non-citizen authorized distributor who fails to transport a
sample of Oxycontin under the proper temperature or in the proper container,
in violation of <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(d)(3)(B)&amp;summary=yes#jcite">21 U.S.C. &sect; 353</a>(d)(3)(B), could be deported from the United
States simply because Oxycontin &mdash; in addition to being a prescription "drug"
&mdash; also happens to contain a "controlled substance." The coincidental
possibility that a controlled substance might be involved with the violation
of a
<span CLASS="page_no" data-cite="687 f 3d 162" data-cite-type="PrimaryFederalReporter" data-cite-pageno="162" data-primary-citation="687 F.3d 150">[*162]</span> 
law or regulation is not enough to make that law or regulation one "relating
to a controlled substance" for deportability purposes under <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(B)(i)&amp;summary=yes#jcite">&sect;
1227(a)(2)(B)(i)</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Though we must interpret the phrase "relating to a controlled substance"
broadly, that phrase must have limits, lest it be bent beyond all logical
meaning. <i>See Denis</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1ETG06003?jcsearch=633%20f%203d%20201&amp;summary=yes#jcite">633 F.3d at 212</a> (noting that we must interpret the
phrase "`relating to' broadly, seeking a logical or causal connection"). We
believe that bringing the FDCA's wholesale distribution provisions within
the scope of that phrase would extend it beyond its breaking point for two
related reasons. First, the connection between &sect; 331(t), 353(e)(2)(A), and
illicit controlled substance-related activity, is too attenuated. Second, &sect;
331(t) and 353(e)(2)(A) criminalize a substantial <span CLASS="page_no" data-cite="2012 bl 180446 p 10" data-cite-type="Bloomberg" data-cite-pageno="10" data-primary-citation="">[**10]</span> swath of conduct with no
nexus to controlled substances as defined in <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976C2003?jcsearch=21%20U.S.C.%20%20802&amp;summary=yes#jcite">21 U.S.C. &sect; 802</a>.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  In this case there is undeniably <i>a</i>connection between the FDCA wholesale
distribution provisions and illicit controlled substance-related activity:
the FDCA prohibits the unlicensed wholesale distribution of prescription
"drugs," the CSA in turn criminalizes the unauthorized distribution of
"controlled substances," and some prescription "drugs" are also "controlled
substances." But that nexus, though simply stated, is not at all evident
from the face of &sect; 331 (t) and 353(e) and only emerges after a journey
through other laws, regulations, and governmental publications. To repeat, &sect;
331(t) and 353(e) do not use the term "controlled substance" nor do they
list specific prescription drugs that are in fact controlled substances. To
see the connection between prescription drugs and controlled substances, we
must rummage through the 400-plus page "Prescription Drug Product List" in
the FDA's Orange Book, <i>see Approved Drug Products with Therapeutic</i>
<i>Equivalence Evaluations, supra</i>at 3-1 to 3-24, and then hunt for a match in
the roughly 100 pages of schedules of controlled substances in the Code of
Federal Regulations, <i>see</i>21 C.F.R. &sect; 1308.11-.15. Even if we complete this
odyssey, the fruits of our labor are for naught. It is inconsequential under
&sect; 331 (t) and 353(e)(2)(A) if the prescription drugs at issue are also
controlled substances "(as defined in section 802 of Title 21)." Thus, the
"relationship" between &sect; 331 (t) and 353(e)(2)(A) and "controlled
substances" is a mere coincidence devoid of any legal significance under the
FDCA.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  Moreover, the FDCA wholesale distribution provisions, which (to repeat)
define a single offense and not distinct and separate offenses, prohibit a
wide range of behavior completely unconnected to controlled substances. The
statutes are blind to whether a particular prosecution involves highly
addictive prescription pain-killers, or relatively benign prescription
shampoos, topical creams, or eye drops. In this regard, we believe &sect; 331 (t)
and 353(e)(2)(A) to be analogous to a law criminalizing the receipt of
stolen property. In Pennsylvania, for example, a person may be convicted of
theft if he intentionally receives property knowing that it has been stolen.
<i>See, e.g.</i>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XC862A003?jcsearch=18%20p%20s%20sc%203925&amp;summary=yes#jcite">18 Pa.C.S.A. &sect; 3925</a>(a). Whether that stolen property includes
Oxycontin or cotton candy is inconsequential under the statute. Like &sect; 331
(t) and 353(e)(2)(A), the Pennsylvania receipt-of-stolen-property statute
reaches countless activities that are completely unconnected to controlled
substances. Classifying such a law as one "relating to a controlled
substance" would stretch too far the bounds of the phrase "relating to."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  * * * * * *
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
  We hold that (1) a conviction for violating the FDCA's wholesale
distribution provisions, <i>see</i>21 U.S.C. &sect; 331(t) &amp; 353(e)(2)(A), is not an
"aggravated felony" &mdash; specifically
<span CLASS="page_no" data-cite="687 f 3d 163" data-cite-type="PrimaryFederalReporter" data-cite-pageno="163" data-primary-citation="687 F.3d 150">[*163]</span> 
"illicit trafficking in a controlled substance (as defined in section 802 of
Title 21), including a drug trafficking crime (as defined in section 924(c)
of Title 18)" &mdash; under 8 U.S.C. &sect;.&sect; 1101(a)(43)(B) and 1227(a)(2)(A)(iii),
and (2) the FDCA's wholesale distribution provisions are not laws "relating
to a controlled substance (as defined in Section 802 of Title 21)" under
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(B)(i)&amp;summary=yes#jcite">8 U.S.C. &sect; 1227</a>(a)(2)(B)(i).<a HREF="#fn900" name="fnref_fn900">[fn9]</a> Accordingly, we grant the petition for
review, reverse, and vacate the order of removal.
<span CLASS="page_no" data-cite="2012 bl 180446 p 11" data-cite-type="Bloomberg" data-cite-pageno="11" data-primary-citation="">[**11]</span> </p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn100" name="fn100">[fn1]</a></span> These drugs are prescribed for people with the human immunodeficiency
virus (Combivir, Serostim, Zerit), fungal infections (Diflucan), severe pain
(Oxycontin), schizophrenia (Zyprexa), and erectile dysfunction (Viagra).
<i>See</i>The National Center for Biotechnology Information,
<i>http://www.nobi.nlm.nih.gov/</i>(last visited July 17, 2012).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn200" name="fn200">[fn2]</a></span> There is no plea agreement or plea colloquy transcript in the
administrative record.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn300" name="fn300">[fn3]</a></span> "We have also previously questioned whether a BIA decision is entitled
to deference when, as here, the BIA has affirmed without opinion the
decision of the IJ pursuant to <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XU6260003?jcsearch=8%20cfr%201003%201&amp;summary=yes#jcite">8 C.F.R. &sect; 1003.1</a>(e)(4)." <i>Ng v. Att'y Gen.</i>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1447SI003?jcsearch=436%20f%203d%20392&amp;summary=yes#jcite">436 F.3d 392</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1447SI003?jcsearch=436%20f%203d%20392&amp;summary=yes#jcite">395</a> n. 4 (3d Cir.2006); <i>see also Smriko v. Ashcroft</i>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XFPOB5?jcsearch=387%20f%203d%20279&amp;summary=yes#jcite">387 F.3d 279</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XFPOB5?jcsearch=387%20f%203d%20279&amp;summary=yes#jcite">289</a> n. 6 (3d Cir.2004) ("[I]t would seem to be, at the very
least, an open question as to whether an IJ's decision affirmed through the
streamlining process would be entitled to <i>Chevron</i>deference . . . [D]eferring
to the reasoning of an IJ from which the BIA would be free to depart in
other cases would seem highly problematic."); <i>Singh v. Att'y Gen.</i>,
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XFPG73?jcsearch=383%20f%203d%20144&amp;summary=yes#jcite">383 F.3d 144</a>, <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XFPG73?jcsearch=383%20f%203d%20144&amp;summary=yes#jcite">152</a> (3d Cir.2004) ("[T]he BIA, by affirming without opinion,
gave no considered and authoritative agency-wide interpretation of the
statute ").
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn400" name="fn400">[fn4]</a></span> The Government does not defend the IJ's aggravated felony analysis.
Instead, it asks that we remand this case to the BIA to give it "an
opportunity to reconsider the immigration judge's determination that Mr.
Borrome is removable as an aggravated felon under
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(A)(iii)&amp;summary=yes#jcite">8 U.S.C. &sect; 1227</a>(a)(2)(A)(iii)" if we conclude that he is not removable under
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEH10G003?jcsearch=8%20U.S.C.%20%201227(a)(2)(B)(i)&amp;summary=yes#jcite">8 U.S.C. &sect; 1227</a>(a)(2)(B)(i) for having been convicted of a law "relating to
a controlled substance." Gov. Br. at 17. According to the Government, a
remand would give the BIA "an opportunity to reconsider the [IJ's]
determination that the `hypothetical federal felony' approach applies in the
current situation where the statute of conviction, the FDCA, was neither a
state statute nor one of the three statutes enumerated in
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEHS54003?jcsearch=18%20U.S.C.%20%20924%20(c)(2)&amp;summary=yes#jcite">18 U.S.C. &sect; 924</a>(c)(2)." <i></i><cite>Id.at 17</cite> n.9. It would also give the BIA "an
opportunity to reconsider the application of the categorical approach to the
aggravated felony determination in this case." <i><cite>Id</cite>.</i>
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
We decline the Government's request. When Borrome appealed the IJ's ruling
to the BIA, the Government filed a motion for summary affirmance, claiming
(among other things) that "the result reached in the decision under review
is correct . . . and that the issues on appeal are squarely controlled by
existing precedent and do not involve the application of precedent to . . .
novel facts." A.R. at 19. The BIA obliged. Now the Government is singing a
different tune. It gives no good reason why the BIA should have a second
chance to consider the issues raised on this appeal: The BIA had the
opportunity to consider the issues and, at the Government's insistence,
chose not to do so.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn500" name="fn500">[fn5]</a></span> We have found no precedent for using a conviction under
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5MC003?jcsearch=21%20U.S.C.%20%20331(t)&amp;summary=yes#jcite">21 U.S.C. &sect; 331</a>(t) and <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5OK003?jcsearch=21%20U.S.C.%20%20353(e)(2)(A)&amp;summary=yes#jcite">353</a>(e)(2)(A) as a basis for removability.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn600" name="fn600">[fn6]</a></span> A "drug" means
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
(A) articles recognized in the official United States Pharmacopeia, official
Homeopathic Pharmacopeia of the United States, or official National
Formulary, or any supplement to any of them; and (B) articles intended for
use in the diagnosis, cure, mitigation, treatment, or prevention of disease
in man or other animals; and (C) articles (other than food) intended to
affect the structure or any function of the body of man or other animals;
and (D) articles intended for use as a component of any article specified in
clause (A), (B), or (C).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/XEI5M2003?jcsearch=21%20U.S.C.%20%20321(g)(1)&amp;summary=yes#jcite">21 U.S.C. &sect; 321</a>(g)(1).
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn700" name="fn700">[fn7]</a></span> As discussed above, the FDCA wholesale distribution provisions are
non-divisible statutes that define a single offense. Therefore, we apply the
formal categorical approach to determine whether they are laws "relating to
a controlled substance."
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn800" name="fn800">[fn8]</a></span> For example, to achieve this correspondence, Congress could have made
removable any alien convicted of an offense "involving a controlled
substance (as defined in <a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1976C2003?jcsearch=21%20U.S.C.%20%20802&amp;summary=yes#jcite">section 802</a> of Title 21)" or an offense "punishable
under" the CSA.
</p></div>
<div id="paraOpinion" printdualcolumn="true"><p class="opinion_text">
<span class="fr"><a HREF="#fnref_fn900" name="fn900">[fn9]</a></span> We note that our holding today should have very little effect on the
vast majority of aliens convicted in federal court for violating federal
controlled substances laws. Inexplicably, Borrome was not charged with
violating the CSA, even though one of the seven prescription drugs listed in
his indictment was a controlled substance. If he had been convicted of
violating the CSA, he almost certainly would be removable.
</p></div>
<!--BBLS DD 1718480207875-->

</div>
<div class='sideBar printHide clearfix '>
<!-- /Default state -->
<!-- /Display properties -->
<div class='tabsNotepad printHide'>
<div class='tabButtons clearfix'>
<div class='borderTab activeTab' id='buttonTab_general'>
<span>
General Info
</span>
</div>
<div class='borderTab inactiveTab' id='buttonTab_notePad'>
<span>Notepad</span>
</div>
</div>
</div>
<div class='sideBarInner clearfix'>
<div class='sideBarContent bootstrap sidebar ' id='tab_general'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span class='left'>BCite Analysis</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider bciteRenderer clearfix'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1I0EME003/history">Direct History (1)</a>
</div>
<div class='sidebarItemLabel bold'>
No Negative Direct History
</div>
</div>
<div class='bciteRenderer clearfix sidebarSectionDivider sidebarSubsection'>
<div class='sidebarSubhead bold'>
<a href="/bcite/X1I0EME003/analysis">Case Analysis (8)</a>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/positive.png'>
<div class='citation icon positive printHide' title='Positive'></div>
<a class='citationAnalysisLabel' href='/bcite/X1I0EME003/analysis?analysis=BCITE_POSITIVE_GROUP'>
Positive
</a>
<span class='citationNumberLabel'>
7
</span>
</div>
<div class='bciteResult'>
<img class='icon printOnly' src='/images/citation_icons/distinguished.png'>
<div class='citation distinguished icon printHide' title='Distinguished'></div>
<a class='citationAnalysisLabel' href='/bcite/X1I0EME003/analysis?analysis=distinguished'>
Distinguished
</a>
<span class='citationNumberLabel'>
1
</span>
</div>
</div>
<div class='sidebarSubsection clearfix analysisLink'>
<div class='sidebarSubhead small'>
<a href="https://www.bloomberglaw.com/help/BCite_Indicators.htm" class="citatorRenderer">Description of BCite Indicators</a>
</div>
</div>

<div id='generalInfo'>
<div class='sidebarSection'>
<div class='sidebarTitle'>
<span>
General Information
</span>
</div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Result(s)</div><div class='facetItemLabel'>Order Reversed, Order Vacated, Appeal Granted</div></div>
<div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Related Docket(s)</div><div class='facetItemLabel'><a href="/s/opinion/8f3051fbc9668851a43a791809511210/document/X1Q6LJ89VU82">11-01975 (3d Cir.)</a></div></div><div class='sidebarSubsection sidebarSectionDivider'><div class='facetItemHeading'>Topic(s)</div><div class='facetItemLabel'>Administrative Law</div><div class='facetItemLabel'>Criminal Law</div><div class='facetItemLabel'>Immigration &amp; Naturalization</div></div>
<div class='sidebarSubsection' id='judges_section'>
<div class='facetItemHeading'>Judge(s)</div>
<div id='judges_section_loader'></div>
</div>
</div>
</div>
</div>
</div>
<div class='sideBarContent clearfix notepad hidden' id='tab_notePad'>
<div id='notepad'>
<div class='notepadInstructions'>
Click anywhere in Notepad to add a note.
</div>
<div class='protoNote note'>
<a class='anchor'></a>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
<div class='ieFloat right'>
<a class='delete'>
Delete
</a>
<div class='toolDivider'>
|
</div>
<a class='edit'>
Edit
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='body'></div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay'></span>
</div>
<div class='ieFloat right'>
<a class='next'>
Next
</a>
</div>
</div>
</div>
<div class='protoNoteEditor note'>
<div class='headerRow'>
<div class='ieFloat'>
<span class='title'></span>
<span class='date'></span>
</div>
</div>
<div class='body'>
<textarea class='contents'></textarea>
<div class='toolRow'>
<a class='save'>
Save
</a>
<div class='toolDivider'>
|
</div>
<a class='cancel'>
Cancel
</a>
<div class='clearfix'></div>
</div>
</div>
<div class='footer'>
<div class='ieFloat'>
<a class='previous disabled'>
Previous
</a>
</div>
<div class='ieFloat pageDisplay'>
<span class='numNoteDisplay disabled'></span>
</div>
<div class='ieFloat right'>
<a class='next disabled'>
Next
</a>
</div>
</div>
</div>
<div class='protoConfirmDelete'>
<div class='popupWindowOuter'>
<div class='popupWindowInner'>
<div class='clearfix popupTitle'>
<div class='close' onclick='closePopup()'></div>
<h2>
Delete Note
</h2>
</div>
<div class='popupContent'>
<div class='sectionLabel'>
Are you sure you want to delete this note?
<br>
<br>
<br>
<br>
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right'>
<span>
Delete
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='closePopup()'>
<span>
Cancel
</span>
</button>
</div>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class='clearfix'></div>
</div>

<div class='keywordSearch' id='keyword_search'>
<a href="javascript:Blaw__findPrevKeyWord();redrawPrevNextButtons();" id="keyword_search_previous">Previous Keyword</a>
|
<a href="javascript:Blaw__findNextKeyWord();redrawPrevNextButtons();" id="keyword_search_next">Next Keyword</a>
</div>
<div class='pageLoader'></div>
<div class='browserPopupContainer' id='browserPopup'>
<div class='browserTitle'>
<div class='close' onclick='$("#browserPopup").bbTocBrowser(false);'></div>
<h2 class='popup_title'></h2>
</div>
<div class='browserPopupContent popup_content' id='browserPopupContent'></div>
</div>
<div class='maskOverlay' id='ajax_browser_mask'></div>


<div class='clearfix'></div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->
<div class='clientMatterContainer hidden' id='clientMatterContainer'>
<form accept-charset="UTF-8" action="/client_matter/session/create" id="startClientMatterSessionForm" method="post"><div style="margin:0;padding:0;display:inline"><input name="utf8" type="hidden" value="&#x2713;" /><input name="authenticity_token" type="hidden" value="NiJ+70/qv61N1TFnbttr4ZzRa7IGhB5DMvou0CKGUXA=" /></div>
<input id="create_client_matter" name="create_client_matter" type="hidden" value="false" />
<div class='clearfix popupTitle'>
<div class='close' onclick='cancelClientMatterPopup()'></div>
<h2>
Enter a Client Matter
</h2>
</div>
<div class='popUpContent'>
<div class='clientMatterPopupHeader'>
Your firm optionally allows a client matter to be selected while you are using Bloomberg Law.
Please select from a recently used Client Matter or enter a Client Matter manually.
</div>
<div class='error' id='clientMatterLabelErrors' style='display:none'></div>
<div class='error' id='attorneyNumberLabelErrors' style='display:none'></div>
<div class='row sources clearfix'>
<div class='labelHolder'>
<span class='label'>Client Matter</span>
</div>
<div class='inputContainer'>
<input autocomplete="off" class="autocompleteTextField input_auto autocompleteForm" data-context="CLIENT_MATTERS" data-highlight-term="true" data-select-callback="applyClientMatterFromAutocompleteSelection" data-show-no-matches="false" data-url="/autocomplete/lookup" id="client_matter_label" name="client_matter_label" type="text" value="" />
<script type="text/javascript">
//<![CDATA[
jQuery().ready(function ($) { $('#client_matter_label').bbAutocomplete(); });
//]]>
</script>
</div>
</div>
<div class='row clientMatterSuppressionCheckholder' id='clientMatterSuppressionCheckholder'>
<label>
<input id="suppress_client_matter_prompt_enabled" name="suppress_client_matter_prompt_enabled" type="hidden" value="1" />
<input checked="checked" id="suppress_client_matter_prompt" name="suppress_client_matter_prompt" type="checkbox" value="1" />
<label for="suppress_client_matter_prompt">Do not remind me again this session</label>
</label>
</div>
<div class='clientMatterText'>
Please contact your administrator if you have questions about client matter.
</div>
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup right' type='submit'>
<span>
Submit
</span>
</button>
<button class='bootstrap skinButton popup cancel right' onclick='cancelClientMatterPopup();' type='button'>
<span>
Cancel
</span>
</button>
</div>
</form>

<div id='createClientMatterForm' style='display:none'>
<div class='clearfix popupTitle'>
<h2>
Unrecognized Client Matter
</h2>
</div>
<div class='div'>
Client Matter
<span id='new_client_matter_label'>&nbsp;</span>
does not currently exist in Bloomberg Law. Would you like to add this client matter to the system?
</div>
<div class='popUpActions'>
<button class='bootstrap skinButton popup action right' type='button'>
<span>
Yes
</span>
</button>
<button class='bootstrap skinButton popup cancel right' type='button'>
<span>
No
</span>
</button>
</div>
</div>
</div>
<!-- _enter_client_matter.haml begin -->

<div id='loading_container'></div>
<div class='fixedControls menuHolder printHide' id='bottom_menu_row'>
<div class='menuButton' id='pde_tray_menu'>
<div class='queueImageHolder'></div>
<div class='indicator num_of_pde_tray_items'></div>
</div>
<div class='clearfix'></div>
</div>
<div class='menuItem bottomMenu' id='pde_tray'>
<div class='inner'>
<div class='heading'>
<div class='title'>
Queue
<span class='indicator num_of_pde_tray_items'></span>
<!-- =pde_tray_count_from_session -->
</div>
<div class='bootstrap closeIcon right' id='pde_tray_close_button'></div>
<div class='clearfix'></div>
</div>
<div class='actions hasItems' id='pde_tray_has_items'>
<div class='selection'>
<div class='trayCheckHolder'>
<input id='pde_tray_select_all' type='checkbox'>
</div>
Select All
</div>
<div class='tools'>
<a onclick='javascript:PDETray_default.downloadSelection();'>
Print/Download
</a>
|
<a onclick='javascript:PDETray_default.emailSelection();'>
Email
</a>
|
<a onclick='javascript:PDETray_default.workspaceSelection();'>
+ Workspace
</a>
|
<a onclick='javascript:PDETray_default.deleteSelection();'>
Delete
</a>
</div>
<div class='clearfix'></div>
</div>
<div class='actions noItems' id='pde_tray_no_items'>
<div class='title'>
You have no items in your Queue
</div>
<div class='clearfix'></div>
</div>
<div class='itemsHolder' id='pde_tray_items'></div>
</div>
</div>

<div class='maskOverlay' id='pde_tray_mask'></div>

<script language='javascript'>
var SHOW_AUDIT = false;
var ROOT_PATH = "/";
var RAILS_ROOT = "/";
var CONTEXT_PATH = "/";
var DOC_ROOT_PATH = "/s/opinion/8f3051fbc9668851a43a791809511210/";
var RESULTS_ROOT_PATH = "/search/results/";
var SELECTED_CONTEXT = "";
var MODULE_PATH;
MODULE_PATH = "/document";
var CRUMB_ID = "8f3051fbc9668851a43a791809511210";
var BILLING_CONFIGURATION = {"DOCKET":true,"NEWS":false,"LAW":true,"ADVANCED_LEGAL":true,"PATENT":true,"PATENT_ASSIGNMENT":true,"PEOPLE":false,"OPINION":true,"CITATION":false,"BREAKING":true,"DOCKET_REQUESTS":true,"COMPANY_FILINGS_EDGAR":false,"COMPANY_FILINGS_DOCKETS":false,"COMPANY_FILINGS_OTHER":false,"CORP_ACTIONS":true,"ECO_SEARCH":true,"EDGAR_SEARCH":true,"EXAMPLE_DOCUMENTS":true,"CLAUSE_SEARCH":true,"LEG":true,"REG":true,"BOOLEAN":false,"SIMPLE":false,"COMPANY_DOCKETS":true,"TOC_SEARCH":true,"IMMUTABLE_LAW_SEARCH":true};
var CONTEXT_BILLING_POLICY_KEY = "";
var ELITE_ENABLED = false;
var CLIENT_MATTER_PROMPT_ENABLED = false;
var CLIENT_MATTER_ON_LOGIN_ENABLED = false;
var SUPPRESS_CLIENT_MATTER_PROMPT = false;
var clientMatterActive = false;
var currentClientMatter = '';
var currentAttorneyNumber = '';
var clientMatterHaltedForm = null;
var USER_ID = 'un=373038066';
var SESSION_ID = '63166_a5929cc15e1bfd637ed52768bec5d196';
var NTPT_REDIRECTED_EVENT = '';
var NTPT_PGEXTRA = '&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITY305d75&previousPageId=&previousActivityInstanceId=ENTITYe90e42&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:11:15-05:00';
var NTPT_GLBLEXTRA = 'un=373038066&sessionId=63166_a5929cc15e1bfd637ed52768bec5d196&auth=true';
var BROWSER_COMPATIBILITY_WARNING = 'false';
var SHOW_MODAL = false;
var JUG;
$(document).ready(function(){
setTimeout(framework_getPageState,500);
framework_bindGlobalResizeElements();
notepad_onDocumentLoaded();
<!-- /DRQS 24932463 -->
$("#downloadPopupLinkForm a").removeAttr("href");
$('#startClientMatterSessionForm').submit(function() {
  createClientMatterSessionFromForm(this);
  return false;
});

var t = $('.clientMattersTableEl');

jQuery.each(t, function(name, value) {
  try {
    var this_value =  $.trim(String(value.innerHTML));
    var this_final_value = this_value.length > 22 ? this_value.substring(0,9)+"..." : this_value;
    value.innerHTML = this_final_value;
  } catch (e) {}
});

$('#startClientMatterSessionForm .recentlyUsed td').click(function() {
  $('#client_matter_label').val($.trim($(this).attr("title")));
});

});
</script>
<script type='text/javascript'>
DOCUMENT_SHOW_SIDEBAR="true";
DOCUMENT_HAS_SIDEBAR_INFO="true";
DOCUMENT_IS_IFRAME="";
NTPT_PGEXTRA = 'documentSearchType=OPINION&docId=X1I0EME003&docType=OPINIONS&contentClass=LEGAL&activityType=ENTITY&subActivityType=DOCUMENT_VIEWED&pageId=&activityInstanceId=ENTITYe90e42&previousPageId=&previousActivityInstanceId=ENTITY24284d&previousActivityType=ENTITY&previousSubActivityType=DOCUMENT_VIEWED&previousActivityTime=2014-02-02T07:11:11-05:00';
FLUID_LAYOUT="false";
FULL_DOC_ID = 'X1I0EME003';
NOTEPAD_UUID="11082191";
NOTEPAD_DOC_ID="X1I0EME003";
$('#page_loader').show().spin();
JUDGE_IDS=["1759813","3055444","3594215"];
JUDGE_NAMES=null;
</script>

<script src="/javascripts/activity_tracking/ni.js?1376494218" type="text/javascript"></script>
<script src="/javascripts/activity_tracking/tracking.js?1384975732" type="text/javascript"></script>
<div class='footer'>
<div class='footerContent printHide'>
<div class='logoContainer grid eight'>
<div class='copyright'>
&copy; 2014 The Bureau of National Affairs, Inc. All Rights Reserved.
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPR08'); return false;">Terms of Service</a>
 | 
<a href="#" class="menuLink" onclick="open_tos_or_privacy('X3BPH08'); return false;">Privacy Policy</a>
</div>
<a class='logo' href='/home'></a>
<div class='version'>
2.
231154
Gem
0.176.7
231497
 - 3.0.20
</div>
<div class='helpContainer'>
<div class='helpDesk'></div>
<a href="/help/BLAWHelpSystem.htm#Contact_Us.htm" class="menuLink">Submit Feedback</a>
 | 
<a href="mailto:blawhelp@bna.com" class="menuLink">blawhelp@bna.com</a>
</div>
</div>
</div>

</div>
</div>
</body>
</html>
